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ABSTRACT 
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by two major 
pathological hallmarks, amyloid plaques and neurofibrillary tangles. The accumulation of 
amyloid-β protein (Aβ) is an early event associated with synaptic and mitochondrial damage in 
AD. Therefore, molecular pathways underlying the neurotoxicity and generation of Aβ represent 
promising therapeutic targets for AD. Recent studies have shown that actin severing protein, 
Cofilin plays an important role in synaptic remodeling, mitochondrial dysfunction, and AD 
pathogenesis. However, whether Cofilin is an essential component of AD pathogenesis and how 
Aβ induced neurotoxicity impinges its signals to Cofilin are unclear.  
In my dissertation studies, we found Aβ oligomers bind with intermediate activation 
conformers of β1-integrin to induce the loss of surface β1-integrin and activation of Cofilin via 
Slingshot homology-1 (SSH1) activation. Specifically, conditional loss of β1-integrin prevented 
Aβ induced Cofilin activation, and allosteric modulation or activation of β1-integrin significantly 
reduced Aβ binding to neurons and mitigated Aβ42-induced reactive oxygen species (ROS) 
generation, mitochondrial dysfunction, synaptic proteins depletion, and apoptosis. Furthermore, 
we found that SSH1 reduction, which mitigated Cofilin activation, prevented Aβ-induced 
mitochondrial Cofilin translocation and apoptosis, while AD brain mitochondria contained 
significantly increased activated/oxidized Cofilin. In mechanistic support in vivo, we 
demonstrated that APP transgenic mice brains contain decreased SSH/Cofilin and SSH1/14-3-3 
complexes which indicates that SSH-Cofilin activation occurred by releasing of SSH from 14-3-
 viii 
 
3. We also showed that genetic reduction in Cofilin rescues APP/Aβ-induced synaptic protein 
loss and gliosis, as well as impairments in synaptic plasticity and contextual memory in vivo.  
Our lab previously found that overexpression of the scaffolding protein RanBP9 
increases Aβ production in cell lines and in transgenic mice, while promoting Cofilin activation 
and mitochondrial dysfunction. However, how endogenous RanBP9 activates cofilin and 
whether endogenous RanBP9 accelerates Aβ-induced deficits in synaptic plasticity, cofilin-
dependent pathology, and cognitive impairments were unknown.  In my dissertation studies, we 
found that endogenous RanBP9 positively regulates SSH1 levels and mediates A-induced 
translocation of Cofilin to mitochondria. Moreover, we demonstrated that endogenous RanBP9 
mediates A-induced formation of Cofilin-actin rods in primary neurons. Endogenous level of 
RanBP9 was also required for Aβ-induced collapse of growth cones in immature neurons and 
depletion of synaptic proteins in mature neurons. In vivo, we also found APP transgenic mice 
exhibit significantly increased endogenous RanBP9 levels and that genetic reduction in RanBP9 
rescued APP/Aβ-induced synaptic protein loss, gliosis, synaptic plasticity impairments, and 
contextual memory deficits. These findings indicated that endogenous RanBP9 not only 
promotes Aβ production but also meditate Aβ induced neurotoxicity via positively regulating 
SSH1. Taken together, these novel findings implicate essential involvement of β1-integrin–
SSH1/RanBP9–Cofilin pathway in mitochondrial and synaptic dysfunction in AD pathogenesis.   
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CHAPTER 1 
 
INTRODUCTION 
Alzheimer’s disease (AD) overview  
Alzheimer’s disease (AD) is a neurodegenerative disorder that is the most common cause 
of dementia. It is a progressive disease that leads to memory loss, confusion, disorientation, and 
difficulty having a conversation. Prevalence rates of AD range from ~10% of individuals >65 
and up to 50% of individuals greater than 85 years of age. The clinical course of AD ranges from 
5 to 15, depending on the age of onset.  Historically, AD was first identified in 1901 by a 
German psychiatrist Alois Alzheimer, whose patient named Auguste Deter presented with AD-
like symptoms, and upon autopsy found ‘milliary foci’ and ‘neurofibrils’ in brain, which were 
later biochemically identified as amyloid plaques and neurofibrillary tangles, respectively.  
Alzheimer’s disease (AD) currently afflicts 5.4 million individuals in the USA. Due to the aging 
population, this number is estimated to rise to 13.2 million by 2050 if no effective treatment is 
found. In 2012, the cost of caring for AD and related dementia patients in the US stood at $200 
billion per year, and this figure is projected to rise to $1.1 trillion per yearr by 2050 (2012 
dollars). Therefore, AD is a tremendous cost to patients and families in both human and financial 
terms. 
 2 
Amyloid plaques and neurofibrillary tangles  
The major pathological hallmarks of Alzheimer’s disease are the Amyloid plaques and 
neurofibrillary tangles. Amyloid plaques are the accumulations of amyloid β (Aβ) protein, 
largely in extracellular space, while neurofibrillary tangles are the intraneuronal inclusion of 
hyperphosphorylated tau. Aβ is a neurotoxic peptide derived from amyloid precursor protein 
which is cleaved by β-, and γ-secretases (APP PROCESSING FIGURE). The vast majority of 
APP is normally cleaved in the middle of the A sequence by -secretase 
(ADAM10/TACE/ADAM17) in the non-amyloidogenic pathway, thereby preventing the 
generation of an intact A peptide. Alternatively, a small proportion of APP is cleaved in the 
amyloidogenic pathway, leading to the secretion of A peptides (37 to 42 amino acids) via two 
proteolytic enzymes, - and -secretase, known as BACE1 and presenilin, respectively (De 
Strooper & Annaert, 2000a). The proteolytic processing of APP to generate A requires 
endocytosis from the cell surface and localization to cholesterol-rich membrane rafts where both 
BACE1 and the presenilin complex are enriched (Koo & Squazzo, 1994; Perez et al., 1999; 
Wahrle et al., 2002).  
Neurofibrillary tangles are composed of the microtubule associated protein tau. 
Hyperphosphorylated tau assembles into twisted filaments seen by electron microscopy as paired 
helical filaments or PHFs, which are immunopositive with AD-specific diagnostic antibodies, 
such as AT100 or AT8 (Avila, Lucas, Perez, & Hernandez, 2004). Although tau 
stabilizes/associates with microtubules within somatoaxonal compartments under normal 
physiological conditions, tau becomes hyperphosphorylated during early stages of AD, which 
weakens its association to microtubules and often mislocalizes to somatodendritic compartments. 
Thus, hyperphosphorylated tau is unable support microtubule stabilization, mislocalizes to 
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dendritic compartments, and becomes increasing prone to self-aggregation (Gendron & 
Petrucelli, 2009).   
Genetic basis of Alzheimer’s disease (AD) 
Early onset AD 
Early onset AD occurs before the age 65. Of this group, familial early-onset AD (FAD) 
patients are those whose genetic causes have been identified. In 1991, the amyloid hypothesis 
was postulated that the accumulation of  A is the fundamental cause of AD rather than simply 
pathological hallmarks of the disease (Hardy & Allsop, 1991). This hypothesis was initially 
supported by the identification of mutations in APP that co-segregated with FAD patient 
families. Of important note, all of the FAD mutations identified thus far are concentrated near 
the -secretase or -secretase cleavage sites in APP such that either total A or the more 
pathogenic A42 peptide is increased. While presenilin-dependent -secretase cleavage of APP 
at A residue 42 (A42) is a minor species (~10%) compared to A40 (>80%), many studies 
have shown that A42 is more neurotoxic and is required to efficiently seed the aggregation of 
A40 (Glabe, 2008). Recently, a new Icelandic mutation in near the BACE1 cleavage site was 
identified, which protects against the risk of AD and reduces A secretion by ~40% (Jonsson et 
al., 2012). Furthermore, individuals with trisomy 21 (Down’s syndrome) with an extra copy of 
the APP gene on chromosome 21 invariably exhibit AD pathology by the 4th decade of life. 
Closer examination of Down’s syndrome brains showed that A42 containing senile plaques 
develop much earlier than neurofibrillary tangles, further supporting the amyloid hypothesis 
(Hyman, 1992; Hyman, West, Rebeck, Lai, & Mann, 1995). In 1995, mutations in two 
homologous genes, Presenilin 1 (PS1) and Presenilin 2 (PS2) were discovered that co-segregated 
with the most aggressive forms of autosomal dominant early-onset FAD. Thus far, more than 
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100 different FAD mutations in PS1 and PS2 have been identified (St George-Hyslop & Petit, 
2005). Further adding support to the amyloid hypothesis, all of the presenilin mutations studied 
were found to increase the more pathogenic and faster aggregating A42 peptide (Table 1-
1)(Figure1-2)(Herz & Beffert, 2000). 
Late onset AD 
The vast majority of AD (>95%) is the late-onset sporadic form and it is not inherited in 
an autosomal dominant pattern. Various different genes have been identified as late onset genetic 
factors, and the most common and strongest genetic risk factor to date is the 4 allele of the 
apolipoprotein E (APOE) gene. APOE ε4 allele increases the risk for the disease by ~3-fold 
among hemizygotes and by ~15-fold among homozygotes (Holtzman, 2001). ApoE4 also 
promotes the accumulation of Amyloid beta far more efficiently than apoE3 (Strittmatter et al., 
1993). Therefore, all known and confirmed genetic component of AD either increase total A, 
the more pathogenic A42 peptide, or aggregation states of A. Recently, genomic-wide 
association studies (GWAS) have allowed the identification of variation in over 20 loci that 
contribute to disease risk such as INPP5D, MEF2C, ZCWPW1, CLU, PTK2B, PICALM, 
SORL1, CELF1, CR1, BIN1, MS4A4/MS4A6E, SLC24A4/RIN3, FERMT2, CD33, ABCA7, 
CASS4, TREM2, CD2AP, HLA-DRB1/HLA-DRB5, EPHA1, NME8. Furthermore, rare variants 
associated with Late-onset AD have been identified in TREM2 and PLD3 gene (Figure1-2). 
Even though various different genes have been found, many of their roles in disease 
pathogenesis still have to be explored. 
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Molecular basis of Alzheimer’s disease (AD) 
Soluble A oligomer hypothesis and hyperphosphorylation of tau 
Biochemical and cellular studies on A-induced neurotoxicity have shown that distinct 
states or species of A have different biological properties. First, A42, while at much lower 
concentration than A40, aggregates faster and seeds the aggregation of A40 (Glabe, 2008). 
Transgenic mice engineered to produce only A40 or A42 cleaved from the familial British and 
Danish Dementia-related BRI protein shows that A40 cannot form aggregates into amyloid 
plaques even by 18 months of age, while a lesser concentration of A42 induces robust amyloid 
plaque formation even at 12 months of age. Furthermore, the BRI-A42 mice crossed with APP 
Tg2576 mice bearing the “Swedish” mutation exponentially worsens amyloid plaque formation 
(McGowan et al., 2005). Second, A can exist as soluble monomers, dimers, trimers, and higher 
order oligomers (also known as A-derived diffusible ligands; ADDLs) prior to forming 
protofibrils and insoluble amyloid fibrils. These pathological soluble A oligomers cause 
synaptic dysfunction to neurons even at picomolar concentrations. Studies have shown that SDS-
stable dimers and trimers derived from the 7PA2 cell line expressing an FAD APP mutation 
impair long term potentiation (LTP), the physiological correlate of learning and memory, at 
subnanomolar concentrations (D. M. Walsh et al., 2002). Furthermore, soluble SDS-resistant A 
dimers derived from AD brains lead to hyperphosphorylation of tau and neuritic degeneration in 
primary hippocampal neurons at picomolar concentrations (Jin et al., 2011). Recently, a new 
mutation in APP was identified in a Japanese family with AD-type dementia. This mutation 
occurred as a deletion of residue 22 (glutamic acid) of the A peptide (E22). Biochemically, 
the E22 mutation is more resistant to degradation, unable to form fibrils, but far more prone to 
self-association as A oligomers in the form of SDS-stable dimers and trimers (Tomiyama et al., 
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2008). Expression of this APP mutation in transgenic mice leads to learning and memory deficits 
associated with impaired LTP, enhanced neuroinflammation, and tau hyperphosphorylation in 
the absence of any thioflavin S positive amyloid plaques. This indicated that A oligomers are 
sufficient and fibrillar amyloid deposition is not necessary for A-induced neurotoxicity and 
learning and memory deficits (Nishitsuji et al., 2009). Interestingly, loss of one copy of IGF-1 
receptor, which lengthens lifespan, was shown to be protective by promoting faster aggregation 
of A and increasing the density of amyloid plaques, thereby sequestering toxic soluble A 
oligomer species into amyloid fibrils (Cohen et al., 2009). While it appears that amyloid fibrils 
per se might be less neurotoxic than soluble A oligomers, it is important to note that amyloid 
fibrils can disaggregate into soluble A oligomers, and thus, may serve as stable sources of these 
neurotoxic species. 
Many studies have shown that A promotes the hyperphosphorylation of tau in vitro and 
in vivo (Avila et al., 2004; Gendron & Petrucelli, 2009). A also increases the number of 
neurofibrillary tangles in transgenic mice engineered to express a Frontotemporal Dementia 
(FTDP-17) tau mutation (Lewis et al., 2001). Moreover, depletion of A by injection of an 
antibody directed against A also leads to reduced tau pathology in the APP/tau/presenilin-1 
mutant triple transgenic mice (Oddo, Billings, Kesslak, Cribbs, & LaFerla, 2004), further 
supporting the model that A promotes tau pathology in vivo. In addition, recent studies have 
demonstrated that many of the toxic effects of A require tau expression, indicating that tau is 
indeed downstream of A-induced neurotoxic signals. Neurite retraction and progressive 
neuronal atrophy are seen when neurons are treated with A but not in neurons derived from tau 
knockout mice (Jin et al., 2011; Rapoport, Dawson, Binder, Vitek, & Ferreira, 2002). 
Furthermore, learning and memory impairment as well as high sensitivity to excitotoxin 
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treatment are present in mutant APP transgenic mice but not in the same transgenic mice on a tau 
homozygous tau knockout background, even though A deposition is not affected by tau 
(Roberson et al., 2007). A also induces impairments in LTP and axonal transport of 
mitochondria; however, such impairments are not seen in tau knockout neurons (Shipton et al., 
2011; Vossel et al., 2010), indicating that tau is required for multiple facets of A-induced 
neurotoxicity. Indeed, A oligomers rapidly lead to disassembly of microtubules but only in cells 
expressing tau (King et al., 2006). This is particularly important in neurons, as the microtubule 
network is critical for processes as axonal transport of key proteins and organelles to the synapse. 
Therefore, A-induced hyperphosphorylation of tau appears to partially explain microtubule 
disassembly and impaired excitatory synaptic transmission. It is important to note that like 
soluble A oligomers, soluble hyperphosphorylated tau rather than PHF tau may represent the 
toxic species, since turning off FTD mutant tau expression in an inducible transgenic model does 
not remove insoluble PHF-1 positive tangle-like structures over several months but improves 
learning and memory (Santacruz et al., 2005). 
Amyloid β and its surface receptors  
Although it is clear that Aβ oligomers are neurotoxic at least in part by transmitting 
neurotoxic signals, what types of neuronal surface receptors and intracellular signals are needed 
to transmit these Aβ-induced neurotoxic signaling has remained to be fully elucidated. It has 
been reported that Aβ binds to various different neuronal receptors such as N-methyl-D-aspartate 
(NMDA), nicotinic (α7nAChR), p75NTR receptors. Aβ binding to NMDA receptors has been 
reported to increase calcium influx and potentiate NMDAR activation, but other conflicting 
reports have shown that Aβ oligomers depress LTP and cause progressive loss of dendritic 
spines associated with reduced excitatory synaptic transmission and removal of glutamate 
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receptors from spines (Hsieh et al., 2006b; Pena, Gutierrez-Lerma, Quiroz-Baez, & Arias, 2006; 
G. M. Shankar et al., 2007). Conflicting reports have also shown that Aβ can act as both agonist 
and antagonist of α7nAChR (Dineley et al., 2001; Pettit, Shao, & Yakel, 2001). The binding of 
Aβ to p75NTR, especially in cholinergic neurons of the basal forebrain where this receptor is 
enriched, is associated with death of these neurons. In p75NTR knockout mice, such Aβ-induced 
degeneration of the basal forebrain is not observed (Yaar et al., 1997). Therefore, targeting the 
Aβ/p75NTR interaction appears to represent a promising therapeutic strategy, especially for the 
cholinergic system. Recently, 2 other neuronal surface receptors for A oligomers have been 
proposed, namely PrPc/mGluR5(Lauren, Gimbel, Nygaard, Gilbert, & Strittmatter, 2009; Um et 
al., 2013) and Pir-B(T. Kim et al., 2013).  These receptors bind specifically to A oligomers but 
not fibrils and are required for A-induced deficits in LTP in acute hippocampal slices (Figure 1-
4)(Overk & Masliah, 2014).  
In addition to the aforementioned receptors, integrin adhesion receptors have also been 
shown to mediate A-induced neurotoxicity and deficits in LTP. The integrin family mediates 
both cell-cell and cell-substratum adhesion by binding their extracellular ligands such as laminin 
and fibronectin. Integrins consist of an α and a β subunit, and each subunit has a large 
extracellular portion, a single transmembrane segment, and a short cytoplasmic tail (Hynes, 
1992). These cytoplasmic tails bind to intracellular ligands to mediate dynamic cellular 
responses, such as cell adhesion, migration, neurogenesis, apoptosis, and synaptic stability. 
Hence, integrins provide a transmembrane link for the bidirectional transmission of signals 
across the plasma membrane by binding both extracellular and intracellular ligands (Zamir & 
Geiger, 2001). The ability to connect to the actin cytoskeleton is an important part of the 
adhesive function of the integrin family. Within focal adhesions, structural proteins such as 
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vinculin and talin anchor -integrins to the actin cytoskeleton, while signaling proteins such as 
focal adhesion kinase (FAK), Pyk2, Paxillin, and Src mediate downstream signaling events in a 
transient and controlled manner (Cabodi et al., 2010) (Figure 1-2) (Vicente-Manzanares, Choi, & 
Horwitz, 2009). Integrin signaling is also associated with changes in synaptic plasticity and 
neuronal excitability. Glutamate receptors (NMDA and AMPA receptors) are the target of 
integrin-dependent regulation. Interfering with integrin-dependent adhesion by antagonists or 
conditional deletion of 3, 5, and/or 1 integrins leads to defective LTP (Becchetti, Pillozzi, 
Morini, Nesti, & Arcangeli, 2010). Therefore, integrins represent important adhesion receptors 
that can regulate multiple facets of neuronal function and viability. Integrin blocking antibodies 
to α1/β1 or echistatin (a highly selective and potent integrin inhibitor) blocks fibrillar Aβ-
induced MAPK activation and Aβ-induced neurotoxicity in primary neuronal cultures (Anderson 
& Ferreira, 2004). Moreover, antibodies against αv-integrins block the inhibition in LTP induced 
by Aβ. A small molecule nonpeptide antagonist of αv-containing integrins (SM256) and a potent 
disintegrin echistatin also block Aβ-induced inhibition of LTP. Accordingly, a potent ligand of 
αv/ β1 integrin, superfibronectin, also efficiently inhibits Aβ-induced inhibition of LTP (Q. 
Wang et al., 2008a). As glutamate receptors are targets of integrin-mediated regulation, it is 
likely that integrin-mediated alterations in glutamate receptors underlie Aβ-induced inhibition of 
LTP. Addition of soluble Aβ together with fibrillar Aβ dramatically enhances the meshwork of 
Aβ deposition on cortical neurons and induces neurotoxicity in an α2/β1 and αv/β1 integrin 
dependent manner (Wright et al., 2007a). Also, Antibodies against β1, α2, and αv but not α1, α3, 
α4, α5, α6, α9, αv/β 3, αv/β5, or β3 integrins inhibit Aβ-induced neurotoxicity in human primary 
neurons (Wright et al., 2007a). 
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Neuroinflammation in Alzheimer’s disease 
Multiple studies suggest Alzheimer’s disease pathogenesis is not restricted to neuronal 
compartments in the brain. In AD, it has been shown that there is a high expression of 
inflammatory mediators around Aβ deposition and neurofibrilarry tangles, which are associated 
with neurodegeneration (Akiyama et al., 2000). Moreover, it has been also established a link 
between chronic use of non-steroidal anti inflammatories (NSAIDs) and reduced risk of AD 
(Vlad, Miller, Kowall, & Felson, 2008). More Recently, Genome-wide association studies 
identified immure CD33 and TREM2 as AD risk factors indicates the link between immune 
alterations and AD (Guerreiro & Hardy, 2013) .  TREM2 (Triggering Receptor Expressed On 
Myeloid Cells 2) is a microglial activator and act via DAP12 to activate syk-mediated tyrosine 
phosphorylation to promote microglial phagocytosis. CD33 encodes a cell-surface protein of the 
sialic acid-binding Ig-like lectin (SIGLEC) family and provides another example of a myeloid-
cell- or microglial-cell-expressed gene in which variants have been associated with an increased 
risk of developing AD. CD33 expression was upregulated on microglia in human AD. Recently, 
CD33 SNP rs3865444A, which is associated with decreased AD risk has been found (Malik et 
al., 2013; Raj et al., 2014), which is associated with reduced CD33 expression.  
Mitochondrial dysfunction in Alzheimer’s disease (AD) 
Mitochondria, called powerhouse of the cell provide cellular energy, and also involved in 
various different cellular signaling. As the human brain utilizes 20% of total body oxygen 
consumption, mitochondria serve an important capacity in neuronal homeostasis and 
mechanisms of neurodegeneration. Mitochondria have various different biological functions such 
as ATP production, control the energy efficiency, calcium homeostasis, reactive oxygen species 
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(ROS) production, and regulation of apoptotic signaling, all of which play integral roles in 
neurodegeneration seen in AD.  
Given that mitochondria are the most metabolically active organelles, mitochondrial 
dysfunction leads to brain metabolism failure. In AD, aberrant activity of tricarboxylic acid cycle 
(TCA) complexes, pyruvate and isocitrate dehydrogenases, have been reported.  Several studies 
have also shown Aβ deposition is associated with local levels of brain metabolism and neuronal 
activity. Interestingly, Aβ can be directly transported into mitochondria, which perturbs oxygen 
consumption and activity of enzymes in complex III and IV of the respiratory chain. Moreover, it 
has been reported that Aβ in mitochondria is associated with an increase in hydrogen peroxide 
and a decrease in COX activity.  
Mitochondria play essential roles in regulating Ca2+ homeostasis which is pathologically 
linked to neurotoxicity. When Ca2+ levels increase in the cytosol, mitochondria potently take up 
Ca2+ through the mitochondrial Ca2+ uniporter (MCU), resulting in Ca2+ buffering and increased 
metabolism and production of ATP (Bezprozvanny & Mattson, 2008; Matter, Zhang, Nordstedt, 
& Ruoslahti, 1998). However if excess amounts of Ca2+ enter the mitochondria (calcium 
overload), it leads to decreased mitochondrial membrane potential (MMP) and oxidative stress. 
This, in turn, results in formation of the mitochondrial permeability-transition pore (mtPTP) and 
failure to exert Ca2+ buffering capacity, leading to secondary excitotoxicity (Hengartner, 2000). 
Multiple studies have demonstrated that A can dysregulate Ca2+ homeostasis via several Ca2+ 
signaling components (Bezprozvanny, 2009): calcineurin (Kuchibhotla et al., 2008), NMDARs 
(De Felice et al., 2007), AMPARs (Hsieh et al., 2006a, 2006b), and P/Q-type VGCCs (Nimmrich 
et al., 2008). Furthermore, FAD mutations in presenilins (PS), which potentiate A42 generation, 
induce excessive Ca2+ release from the ER through IP3 and ryanodine receptors (Cheung et al., 
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2008; Rybalchenko, Hwang, Rybalchenko, & Koulen, 2008). In AD brains, intracellular Ca2+ 
levels are positively correlated with neurofibrillary tangle formation (McKee, Kosik, Kennedy, 
& Kowall, 1990; Nixon, 2003). We and others have also shown that Aβ induces aberrant changes 
in mitochondrial membrane potential in cultured neurons and astrocytes, which can lead to the 
disruption of mitochondrial Ca2+   homeostasis. In addition, many studies have shown that Aβ can 
overactivate NMDA and AMPA receptors that can ultimately lead to mitochondrial Ca2+ 
overload and mitochondrial damage. This, in turn, results in mitochondrial dysregulation and 
apoptosis.  
Mitochondria serve as prominent sources of reactive oxygen species (ROS) production, 
reactive molecules containing oxygen that regulate cellular signaling and cell death. ROS, at low 
to moderate concentrations, is an important mediator of defense mechanisms against infectious 
agents, various cellular signaling events, and synaptic function. However, if ROS levels exceed 
the amount that can be neutralized by anti-oxidant mechanisms, it eventually results in 
mitochondrial dysfunction and neuronal damage (Andreyev, Kushnareva, & Starkov, 2005), the 
molecular targets of which are DNA, lipids, and protein machineries within the cell and 
mitochondria (Knight, 1997). The role of mitochondrial ROS as inducers of Ca2+ dysregulation 
is well-established. On the other hand, a major cause of ROS production is also Ca2+ 
dysregulation. Thus, oxidative stress and Ca2+ regulation are intricately linked and can 
cooperatively contribute to AD pathogenesis. It has been shown that Aβ oligomers can form 
Ca2+-permeable channels in the plasma membranes (Arispe, Rojas, & Pollard, 1993) and that 
the association of Aβ to membranes is enhanced in the presence of excess phosphatidylserine 
(PtdS) (Lee, Pollard, & Arispe, 2002). Other studies have demonstrated that Aβ treatment 
promotes caspase 3, 8, and 9 activation (Fossati et al., 2010; Z. F. Wang et al., 2010) 
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Furthermore, Aβ induces abnormal mitochondrial dynamics. Specifically, Aβ peptide impairs 
axonal transport of mitochondria, attenuates mitochondrial motility, and alters mitochondrial 
distribution in mouse hippocampal neurons, resulting in synaptic degeneration (Calkins & 
Reddy, 2011). Aβ induces Ca2+ dysregulation by membrane-associated oxidative stress and 
activates calcineurin, an important mediator of synaptic plasticity (Celsi et al., 2007). In addition, 
Aβ induces synaptic dystrophy and dysregulation at least in part due to decreased expression of 
NMDA and EphB2 receptors at the synapse, an event that can be corrected by NMDAR agonists 
(Lacor et al., 2007). Though the exact mechanisms of ROS-induced synaptic degeneration 
remain to be further elucidated, ROS is well known to play important roles in synaptic plasticity. 
Indeed, oxidation of cysteine residues on RynR increases Ca2+ release from the ER and 
oxidation (Hidalgo, 2005) of the same residues on NMDAR decreases the receptor activity 
(Lipton et al., 2002). Therefore, it appears that Aβ induces synaptic deficits via both increasing 
oxidative damage and dysregulating Ca2+ dynamics at the synapse and mitochondria, both of 
which cooperatively contribute to neurodegeneration in AD (Figure 1-3)(Luque-Contreras, 
Carvajal, Toral-Rios, Franco-Bocanegra, & Campos-Pena, 2014). 
Tau pathology is also linked to mitochondrial dysfunction. Transgenic mice over-
expressing the P301L mutant demonstrate a significant reduction in complex V and NADH-
ubiquinone oxidoreductase activity together with impairments in mitochondrial respiration and 
ATP synthesis (David et al., 2005). Tau can be cleaved by caspases 3, 7, and 8 after Asp-421, 
yielding a 421 residue tau fragment that assembles into PHF-like fibrils more rapidly than full 
length tau. Overexpression of this cleaved tau leads to a significant decrease in mitochondrial 
membrane potential and loss of mitochondrial membrane integrity (Quintanilla, Matthews-
Roberson, Dolan, & Johnson, 2009). Moreover, introduction of tau in mature hippocampal 
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neurons results in degeneration of synapses by perturbing mitochondria transport and ATP levels 
at the synapse (Thies & Mandelkow, 2007). N-terminal tau fragments have toxic effects on 
mitochondria and lead to the mitochondrial dysfunction associated with impairments in oxidative 
phosphorylation by distorting the enzyme structure of complex V and the level of adenine 
nucleotide translocator, which ultimately perturbs ATP synthesis in mitochondria (Atlante et al., 
2008). Interestingly, these N-terminal tau fragments are localized in AD synaptic mitochondria 
(Amadoro et al., 2010). Taken together, both A and tau exert deleterious effects on 
mitochondria, events that involve ROS generation and Ca2+ dysregulation, which negatively 
impact synaptic function and neuronal viability. 
Cytoskeletal aberrations in AD   
The cytoskeleton is a dynamic structure mainly composed of microfilaments, 
intermediate filaments and microtubules. Cytoskeleton has multiple biological functions, 
including provision of mechanical resistance, anchorage to the extracellular matrix, and 
functioning as scaffolds for transport of need proteins and organelles (i.e. microtubules). These 
functions regulate various cellar pathways, including cell adhesion, migration, division, and 
survival.  Actin is a globular protein that can forms microfilaments, and it is major components 
of the cytoskeleton that can mediate cell motility. Actin has two distinct states in the cells which 
are a monomeric G-actin and filaments F-actin.  F-actin preferentially polymerizes at one end of 
the filament at steady state, and the difference in polymerization rates between the two ends 
result in a net turnover of the filaments. Multiple studies have shown actin dynamics play 
important roles in dendritic spine morphogenesis, membrane protein trafficking, and synaptic 
plasticity.  
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Role of Cofilin in F-Actin dynamics and mitochondrial dysfunction 
ADF/Cofilin, a family of actin-binding protein is a major regulator of actin dynamics. 
Cofilin modulates actin dynamics depending on the ratio of cofilin to actin. At low cofilin to 
actin ratios, cofilin acts to sever actin filaments, whereas at high cofilin to actin ratios, cofilin 
nucleates actin assembly and stabilizes F-actin (B.W. Bernstein & J.R. Bamburg, 2010). The 
activity of cofilin is tightly regulated by phosphorylation and dephosphorylation on serine-3 of 
cofilin by LIMK and Slingshot-1L (SSH), respectively (Eiseler et al., 2009b). Phosphorylation of 
cofilin by LIMK1, a downstream component of Rac-PAK signaling upon focal adhesion 
activation, serves to inactivate cofilin, whereas dephosphorylation of cofilin by Slingshot-1L 
(SSH) activates cofilin (Figure 1-4)(Chiu, Patel, Shaw, Bamburg, & Klip, 2010). It has also been 
shown that reelin, via a pathway involving Dab1, Src, and PI3K, promotes the phosphorylation 
of cofilin on serine-3, thereby inactivating cofilin (Chai, Forster, Zhao, Bock, & Frotscher, 
2009). Therefore, proper relay of focal adhesion signals downstream of integrin and/or reelin 
activation leads to the phosphorylation and inactivation of cofilin by LIMK1, Src, and potentially 
other kinases, leading to reduced actin dynamics. Multiple studies have shown that cofilin is 
involved in oxidative stress induced cell death via critical mitochondrial mechanism. Upon 
oxidative stress, activated cofilin becomes oxidized on several cysteine residues. This allows 
cofilin to lose its affinity for actin and to translocate to mitochondria, where it induces swelling, 
drop in mitochondrial membrane potential, and cytochrome c release by promoting the opening 
of the permeability transition pore. Furthermore, knockdown of endogenous cofilin by siRNA 
also inhibits both oxidant and staurosporin induced apoptosis, indicating that cofilin is critical for 
mitochondria-mediated apoptosis. Cellular stimuli that generate ROS not only oxidize cofilin to 
promote mitochondrial dysfunction but also activate SSH via oxidation of 14-3-3, a chaperone 
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protein that normally functions to inhibit SSH in the nonoxidized form (J.S. Kim, T.Y. Huang, & 
G.M. Bokoch, 2009). Therefore, enhanced ROS generation by A, tau, and/or other oxidative 
stress can dephosphorylate and activate cofilin. Another critical pathway of cofilin activation is 
via calcium. Calcineurin, a calcium activated phosphatase, dephosphorylates SSH, thereby 
promoting cofilin dephosphorylation and activation (Y. Wang, Shibasaki, & Mizuno, 2005a). 
Given that A increases intracellular Ca2+, it has been reported that A also activates calcineurin 
and dephosphorylates cofilin (Homma, Niino, Hotta, & Oka, 2008). Furthermore, A-induced 
dendritic spine loss is also mediated by a pathway involving calcineurin and dephosphorylation 
of cofilin (G.M. Shankar et al., 2007). Indeed, inhibition of calcineurin by FK506 is 
neuroprotective in transgenic animal models of AD (Hong et al., 2010; Rozkalne, Hyman, & 
Spires-Jones, 2011). Finally, it has been shown that active PAK, a downstream component of 
focal adhesion and Rac signaling, is severely reduced in AD brains. A oligomers induce defects 
in PAK signaling, leading to the activation of cofilin and synaptic pathology. Overexpression of 
active PAK reverses these effects of A oligomers (Ma et al., 2008; Zhao et al., 2006). 
Therefore, A-induced alterations in Ca2+, ROS, and focal adhesion signaling can also induce 
the activation of cofilin, which in turn, dysregulates cytoskeletal dynamics, mitochondria, and 
tau . 
Activated and oxidized cofilin can also form cofilin-actin rods in the form of rod shaped 
bundles of filaments. Cofilin-actin rods form in different cultures cells including primary 
neurons in response to heat shock, osmotic stress, and ATP depletion, and Aβ. Cofilin-actin rods 
have been found in both axons and dendrites of mouse hippocampal and cortical neurons and in 
organotypic hippocampal slices. These cofilin-actin rods can block axonal transports as well as 
transport within neurites. Moreover, a subset of cofilin-actin rods contains hyperphosphorylated 
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tau, indicating that cofilin-actin cytoskeletal dynamics also alter tau pathology (Whiteman et al., 
2009). Indeed, it has been demonstrated that transgenic mice and flies overexpressing FTDP-17 
mutant tau promote F- actin assembly, and hyperphosphorylated tau coprecipitates in rods 
together with cofilin and actin (Fulga et al., 2007). These rod structures resemble striated 
neuropil threads. Cofilin also plays a key role in the organization of actin cytoskeleton in 
dendritic spines as well as Aβ induced spine loss (G. M. Shankar et al., 2007). Thus, cofilin and 
tau may cooperatively control such activity and eventually precipitate in rods that contain cofilin, 
actin, and tau when neurons become further stressed by Aβ-induced neurotoxic signals. 
RanBP9 in APP processing, mitochondria-mediated neurotoxicity, and integrin signaling 
RanBP9, also known as RanBPM, acts as a multi-modular scaffolding protein, bridging 
interactions between the cytoplasmic domains of a variety of membrane receptors and 
intracellular signaling targets. These include Axl and Sky (Hafizi, Gustafsson, Stenhoff, & 
Dahlback, 2005), MET receptor protein tyrosine kinase (D. Wang, Li, Messing, & Wu, 2002), 
and 2-integrin LFA-1 (Denti et al., 2004). Similarly, RanBP9 interacts with Plexin-A receptors 
to strongly inhibit axonal outgrowth (H. Togashi, E.F. Schmidt, & S.M. Strittmatter, 2006) and 
functions to regulate cell morphology and adhesion (Dansereau & Lasko, 2008; Valiyaveettil et 
al., 2008b). We previously demonstrated that the C-terminal 37 amino acids of the low density 
receptor-related protein (LRP) robustly promoted A generation independent of FE65 and 
specifically interacted with Ran Binding Protein 9 (RanBP9). Our initial studies found that 
RanBP9 strongly increases BACE1 cleavage of APP and A generation. In cells expressing wild 
type APP, RanBP9 reduced cell surface APP and accelerated APP internalization, consistent 
with enhanced -secretase processing in the endocytic pathway. The N-terminal half of RanBP9 
containing SPRY-LisH domains not only interacted with LRP but also with APP and BACE1. 
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Overexpression of RanBP9 resulted in the enhancement of APP interactions with LRP and 
BACE1 and increased lipid raft association of APP. Importantly, knockdown of endogenous 
RanBP9 significantly reduced A secretion in Chinese Hamster Ovary cells and in primary 
neurons, demonstrating its physiological role in BACE1 cleavage of APP. We also found that 
RanBP9 overexpression in transgenic mice (APP/PS1;RanBP9-TG) significantly increased Aβ 
load and thioflavin-S positive amyloid in brain compared to single APP/PS1 transgenic mice. 
Moreover, we found that an N-terminal bioactive fragment of RanBP9 protein was significantly 
increased in brains of AD patients (M. K. Lakshmana et al., 2012).  
In addition to its effects on APP processing, our studies have shown a significant role of 
RanBP9 in neurotoxicity and apoptosis. RanBP9 single transgenic mice demonstrated 
significantly increased synapse loss, neurodegeneration, gliosis, and spatial memory deficits. 
Consistent with these in vivo observations, RanBP9 overexpression promoted apoptosis and 
potentiated A-induced neurotoxicity independent of its capacity to promote A generation. 
Conversely, RanBP9 reduction by siRNA or gene dosage mitigated A-induced neurotoxicity in 
HT22 neuroblastoma cells. Importantly, RanBP9 overexpression led to the activation of cofilin, a 
key regulator of actin dynamics and mitochondria-mediated apoptosis, and siRNA knockdown of 
cofilin abolished both A and RanBP9-induced apoptosis (Figure 1-5)(J. A. Woo et al., 2012). 
We later went on to show in primary hippocampal neurons that RanBP9 potentiates Aβ-induced 
reactive oxygen species (ROS) overproduction, apoptosis, and calcium deregulation. Analyses of 
calcium handling measures demonstrated that RanBP9 selectively delays the clearance of 
cytosolic Ca2+ mediated by the mitochondrial calcium uniporter (MCU) through a process 
involving the translocation of cofilin to mitochondria and oxidative mechanisms (Roh et al., 
2013b). Further, RanBP9 retarded the anterograde axonal transport of mitochondria in primary 
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neurons and decreased synaptic mitochondrial activity in brain (Roh et al., 2013b). These data 
indicated that RanBP9, cofilin, and A mimic and potentiate each other to produce 
mitochondrial dysfunction, ROS overproduction, and calcium deregulation, leading to 
neurodegenerative changes reminiscent of those seen in AD. 
Because APP, LRP, and RanBP9 all physically interact with -integrins, we also 
investigated whether RanBP9 alters integrin-dependent cell adhesion and focal adhesion 
signaling. We found that RanBP9 overexpression dramatically disrupts integrin-dependent cell 
attachment and spreading in NIH3T3 and hippocampus-derived HT22 cells, concomitant with 
strongly decreased Pyk2/Paxillin signaling and Talin/Vinculin localization in focal adhesion 
complexes (J. A. Woo et al., 2012). Conversely, RanBP9 knockdown robustly promoted cell 
attachment and spreading, as well as, focal adhesion signaling and assembly (J. A. Woo et al., 
2012). Cell surface biotinylation and endocytosis assays revealed that RanBP9 overexpression 
and RanBP9 siRNA potently reduces and increases surface 1-integrin and LRP by accelerating 
and inhibiting their endocytosis, respectively. Primary hippocampal neurons derived from 
RanBP9 transgenic mice also demonstrated severely reduced levels of surface 1-integrin, LRP, 
and APP as well as neurite arborization (J. A. Woo et al., 2012). Therefore, these data indicated 
that RanBP9 simultaneously inhibits cell adhesive processes and enhances A generation by 
accelerating APP, LRP, and 1-integrin endocytosis. 
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Table 1-1 Genes associated with Alzheimer’s disease  
 
Dominant mutations that cause early-onset AD have been identified in APP, PS1 and PS2, and cause a relative increase in APP 
processing to AThe ApoE4 allele has been identified to late-onset AD in a large number of studies. LRP, a multifunctional 
receptor that binds ApoE and numerous other ligands has been found to be weakly linked to late-onset AD by several studies.  
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Figure 1-1 Amyloid β oligomer receptors   
Putative Aβ oligomer receptors, signaling pathways, and therapeutic targets. A number of potential cell surface molecules 
(insulin receptor, NGF receptor, PrPc, mGluR5, EphA4, EphB2, NMDA, and Flizzed) that mediate the synaptotoxic effects of 
Aβ oligomers have been identified. 
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Figure 1-2 The actin-integrin linkage 
The linkage between the extracellular matrix (ECM, red strand on top) and the actin cytoskeleton (represented by yellow beaded 
coils) is depicted. Integrins (represented by the α- and β-transmembrane subunits in light blue and pink) can bind directly to the 
talin head domain (red sphere). Through its tail domain (red rod), talin can bind directly to actin as well as to other components 
of the linkage, such as vinculin (shown in purple). Vinculin can also bind to actin directly, as well as to the actin cross-linker α-
actinin (shown as a dimer, in green). Both vinculin and α-actinin are anchored to the membrane, and their activity is modulated 
by interactions with phosphatidylinositol (4,5)-bisphosphate (PIP2). Finally, vinculin and FAK (shown in blue) can bind to the 
actin nucleator Arp2/3 (shown as a heptamer in grey). 
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Figure 1-3 Mitochondrial damage in Alzheimer’s disease 
Aβ overproduction damages mitochondria causing dysfunction of mitochondrial complexes I and IV, which result in reactive 
oxygen species (ROS) overproduction and adenosine triphosphate (ATP) depletion. In neurons, ATP depletion may lead to 
neurotransmission dysfunction and altered axonal transport, thus provoking mitochondrial dynamics abnormalities. ATP 
depletion also causes dysfunction of the ATP-dependent ion channels, leading to altered ion balance in the cytosol. ROS increase 
in turn leads to mitochondrial permeability transition pore (MPTP) aperture, which increases mitochondrial damage by allowing 
calcium entrance into the mitochondrial matrix, worsening the electron transport chain and oxidative phosphorylation disruption. 
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Figure 1-4 Cofilin regulates actin remodeling  
The accumulation of polymerized F-actin poses a stimulatory factor in the phosphatase activity of SSH, which leads to net 
dephosphorylation and activation of cofilin. Hereon, the actin-severing function of cofilin maintains the flexibility of remodeled 
actin and enables regeneration of free monomeric actin for further polymerization. 
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Figure 1-5 Schematic model of the RanBP9-cofilin pathway in AD pathogenesis  
As the binding of Aβ to various integrins is critical to transmit its neurotoxic signals, Aβ oligomers are proposed to 
activate/dephosphorylate cofilin via the recruitment of RanBP9 to integrin/APP/LRP complexes. The binding of RanBP9 to 
integrin/APP/LRP complexes accelerates their endocytosis, thereby promoting Aβ generation, disrupting focal adhesions, and 
activating cofilin. Under conditions of oxidative stress such as that induced by Aβ oligomers, oxidized, and dephosphorylated 
cofilin translocates into the mitochondria to open up the mitochondrial permeability transition pore, which induces mitochondrial 
dysfunction and promotes apoptotic processes. Activated cofilin can lead to the formation of cofilin-actin rods, which attract 
hyperphosphorylated tau and promote tau pathology. 
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CHAPTER 2 
 
SLINGSHOT-COFILIN ACTIVATION MEDIATES MITOCHONDRIAL AND 
SYNAPTIC DYSFUNCTION VIA AMYLOID BETA LIGATION TO BETA1- 
INTEGRIN CONFORMERS  
Permissions Statement 
The information in chapter 2, “Slingshot-Cofilin Activation Mediates Mitochondrial and 
Synaptic Dysfunction” has been legally reproduced under the Creative Commons Attribution 
(CC-BY) license. This means the publication is accessible online without any restrictions and 
can be re-used in any way subject only to proper citation.  
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Kang, D. E (2015). “Slingshot-Cofilin activation mediates mitochondrial and synaptic 
dysfunction via Aβ ligation to β1-integrin conformers.” Cell death and differentiation 
(2015) 22, 921-934 
 
Background 
The defining pathological hallmark of Alzheimer’s disease (AD) is the accumulation of 
A in brain associated with tau pathology, synapse loss, cytoskeletal aberrations, mitochondrial 
dysfunction, and cognitive decline. Soluble oligomeric forms of A are thought to be the most 
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toxic species, resulting in synaptic loss and downstream neurotoxicity (D. M. Walsh et al., 2002). 
An early and consistent impairment secondary to A oligomer treatment in primary neurons is 
the shrinkage of dendritic spines (Selkoe, 2008) involving the rearrangement of F-actin 
cytoskeleton in spines and loss of spine-associated proteins such as PSD95 and Drebrin(G.M. 
Shankar et al., 2007; Zhao et al., 2006), as well as impaired mitochondrial function(Du et al., 
2010; Moreira, Santos, Moreno, & Oliveira, 2001). Studies have implicated an involvement of 
the F-Actin-severing protein Cofilin in A-induced dendritic spine changes(G.M. Shankar et al., 
2007; Zhao et al., 2006), accumulation of Cofilin-Actin aggregates / rods in AD brains 
(Minamide, Striegl, Boyle, Meberg, & Bamburg, 2000), and increased Cofilin activity in brains 
of AD patients (T. Kim et al., 2013). Cofilin normally functions as a key regulator of Actin 
dynamics that destabilizes F-Actin. Cofilin is inactivated by phosphorylation on Ser3 by LIMK1, 
whereas its dephosphorylation by SSH1 activates Cofilin(B. W. Bernstein & J. R. Bamburg, 
2010; Kurita, Watanabe, Gunji, Ohashi, & Mizuno, 2008; Niwa, Nagata-Ohashi, Takeichi, 
Mizuno, & Uemura, 2002). Upon oxidative stress and/or Ca2+ elevation(B. W. Bernstein & J. R. 
Bamburg, 2010; J. S. Kim, T. Y. Huang, & G. M. Bokoch, 2009; Roh et al., 2013a), SSH1 is 
activated and active Cofilin becomes oxidized on cysteine residues, resulting in rapid 
mitochondrial translocation to promote mitochondria-mediated apoptosis and induction of 
Cofilin-Actin pathology(B. W. Bernstein, Shaw, Minamide, Pak, & Bamburg, 2012; Klamt et al., 
2009). Despite the circumstantial evidence for the involvement of Cofilin in AD pathogenesis, 
no direct evidence thus far has been presented.  
Heterodimeric Integrins ( &  subunits) comprise major adhesion receptors that regulate 
multiple facets of cellular function, including adhesion, motility, survival, and synaptic 
plasticity(Becchetti et al., 2010). A primary function of Integrins is to link the extracellular 
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matrix to the F-actin cytoskeleton via structural scaffolding proteins such as Talin and Vinculin 
(C. Kim, Ye, & Ginsberg, 2011; Zamir & Geiger, 2001). Among several proposed surface A 
oligomer receptors such as PrPc/mGluR5(Lauren et al., 2009; Um et al., 2013) and Pir-B(T. Kim 
et al., 2013), it has been shown that 2/1 and v/1-integrins are also required to mediate A-
induced apoptosis and impairment in LTP(Q. Wang et al., 2008b; Wright et al., 2007b). 
However, whether A binds directly to integrins and how A engagement alters downstream 
integrin function are unknown. In this study, we explored the mechanistic relationships among 
A42O, 1-integrin, and Cofilin activities in vitro, HT22 cells, primary neurons, and genetically 
modified mice. Here we show that A42O exhibits direct high-affinity binding 1-integrin, 
inducing its conformational alteration, loss of surface 1-integrin, and disruption of integrin-
associated focal complexes as well as mitochondrial and synaptic dysfunction via a pathway 
involving ROS-dependent activation of SSH1 and Cofilin.  
Materials and Methods 
Cells, cDNA Constructs, siRNA Sequences, and Transfections 
Hippocampus derived HT22 and CHO 7WD10 cells were maintained in DMEM 
containing 10% FBS. HT22 and CHO7WD10 cell lines were obtained from Prof. David 
Schubert (Salk Institute, San Diego) and Prof. Edward Koo (UC, San Diego). GFP-Vinculin 
construct was obtained from Professor Ballestrem (University of Manchester, UK)(Humphries et 
al., 2007). The 1-Fc Integrin construct was obtained from Dr. Mould at the University of 
Manchester (UK). The 1-integrin-Fc construct encodes residues 1-708 (1 extracellular region) 
fused in-frame to the hinge regions and CH2 and CH3 domains of human IgG1(Valdramidou, 
Humphries, & Mould, 2008). RNAi sequences targeting Cofilin (5’-
GGAGGACCUGGUGUUCAUC-3’) and SSH1 (5'-GAGGAGCUGUCCCGAUGAC-3') were 
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obtained from Dharmacon. All cells were transfected for 48 hours using lipofectamine 2000 
(Invitrogen) according to the manufacturer’s instructions with either cDNA expression 
constructs, empty vector controls, siRNA duplexes, or control single-stranded denatured control 
siRNAs prior to performing biochemical and/or immunocytochemical assays. All siRNAs were 
transfected at a final concentration of 100nM. Cortical and hippocampal primary neurons were 
derived from postnatal day 0 (P0) pups and grown on Poly-D-Lysine coated coverslips or plates 
as previously described (J. A. Woo et al., 2012).  
Antibodies and Reagents 
Antibodies to APP (6E10, Covance), sAPP (IBL-America), sAPP (IBL-America), 1-
integrin (M-106, Santa Cruz), activated 1-integrin (HUTS-4, Millipore), allosteric 1-integrin 
neutralizing (MAB1965, Millipore), 6D11 (Santa Cruz), Talin (H-300, Santa Cruz), Vinculin 
(hVIN-1, Sigma-Aldrich), Cofilin (D3F9, Cell Signaling), phospho-Cofilin (77G2, Cell 
Signaling), SSH1 (SP1711, ECM Biosciences), pan-14-3-3- (Santa Cruz), Actin (AC-74, Sigma 
Aldrich), Tubulin (TU-02, Santa Cruz), A (D5XD2, Cell Signaling), biotin (B7653, Sigma-
Aldrich), GFAP (Invitrogen), Synapsin I (Invitrogen), PSD95 (Abcam), Drebrin (Abcam), 
MAP2 (Millipore), , HRP-linked secondary antibodies (Jackson Immunoresearch), and 
fluorescently labeled secondary antibodies (Invitrogen) were obtained from the indicated 
sources. The mouse monoclonal anti-RanBP9 antibody was a generous gift from Prof. Elizabetta 
Bianchi (Pasteur Institute, France). Trolox (Cayman), JC-1 (Invitrogen), Mitosox-Red 
(Invitrogen), H2DCF (Invitrogen), NOX inhibitor III (Millipore) were purchased from the 
indicated sources. Synthetic A1-42 and FITC-A1-42, and biotin-A1-42 peptides were 
purchased from American Peptide (Sunnyvale, CA). A1-42 oligomers and fibrils were prepared 
precisely as previously characterized (Dahlgren et al., 2002). Briefly, A1-42 powder was 
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dissolved in HFIP at 1mM for 30min at room temperature, aliquoted to eppendorf tubes, allowed 
to evaporate overnight in fume hood, and subjected to speed vacuum for 1h to remove traces of 
HFIP or moisture. To prepare A oligomers, A1-42 film was then dissolved in DMSO (5mM), 
and F-12 cell culture medium (without phenol) was added to a final concentration of 100M 
A1-42 and incubated at 40C for 24h. 
Cell/Tissue Lysis and Immunoblotting 
Cultured cells or brain homogenates were lysed with lysis buffer (50mM Tris-Cl, 150mM 
NaCl, 2mM EDTA and 1% TritonX-100) unless stated otherwise. For separation of cytosolic 
versus focal adhesion-enriched (F) fractions, cytosolic proteins were first released with saponin 
buffer (0.1% saponin, 25mM Hepes, 75mM potassium acetate) for 10min on ice followed by 
extraction of remaining proteins by 2X SDS sample buffer and sonication (Kang et al., 2002; 
Soriano et al., 2001). For isolation of mitochondria, mitochondrial isolation kit (Thermo 
Scientific, IL, USA) was used according to the manufacturer’s instructions for cultured cells. 
Protein quantification was performed by a colorimetric detection reagent (BCA Protein Assay, 
Pierce). Equal amounts of protein were subjected to SDS-PAGE and transferred to nitrocellulose 
membranes for immunoblotting. After probing with the primary antibody, the corresponding 
peroxidase-conjugated secondary antibody was detected by ECL western blot reagents (Pierce). 
ECL images were captured by the Fuji LAS-4000 imager and quantified using the Image J 
software. 
Cell Surface Biotinylation Assay 
Surface biotinylation assays were performed as we previously documented(Lakshmana et 
al., 2009). Briefly, confluent cells in 6 well plates were washed three times in PBS and treated 
with 2.0 mg/ml sulfo-NHS-LC-biotin in Phosphate buffered saline (PBS), pH 8.0 under gentle 
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shaking for 1 h on ice. The cells were then washed three times in PBS and lysed in 1% Triton-X-
100 lysis buffer. Biotinylated proteins were isolated by pull down with anti-biotin antibody 
together with anti-mouse agarose beads (American Qualex). APP (6E10, Covance) and 1-
integrin (M-106, Santa Cruz Biotechnology) within anti-biotin immune complexes were detected 
by immunoblotting with the indicated antibodies.  
Annexin V / PI Apoptosis Assay 
To examine the stage of apoptotic cells, measurements were carried out using FACS 
Calibur (BD Bioscience, San Jose, CA) or fluorescence microscopy.  Cells were either 
trypsinized/collected stained in solution or directly stained on glass coverslips with Annexin V-
fluorescein and PI for 20 min at 25℃ in the dark state using the FITC Annexin V apoptosis 
detection kit I (BD, San Diego, CA). After washing with ice-cold PBS, cells were measured by 
flow cytometry or by fluorescence microscopy as previously described (J. A. Woo et al., 2012). 
FITC-A1-42 Oligomer Binding to Primary Neurons and HT22 Cells 
DIV21 hippocampal neurons or HT22 cells were incubated with FITC-A42O (100nM) 
for 1-2h. Cells were then washed extensively with PBS, fixed with 4% paraformaldehyde, 
stained with DAPI, and fluorescent images were acquired using the Olympus FV10i confocal 
microscope. All comparison images were acquired with identical laser intensity, exposure time, 
and filter. Adjustments to the brightness/contrast were applied equally to all comparison images. 
Purification of 1-integrin-Fc and Binding to A42O 
CHO cells in 10cm plates were transfected with 12g 1-integrin-Fc constructs for 48h. 
Conditioned medium was collected for 24h thereafter and spun for 5min at 1000g. Proteins in 
expressed in conditioned medium were captured by the anti-Fc affinity column and eluted by 
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several rounds. 96-Well plates were coated with goat anti-human-Fc at a concentration of 5g/ml 
in DPBS (50 l/well) for 16h. Wells were washed with DPBS (100 l/well) and then blocked for 
1 h with 100l of 5% (w/v) bovine serum albumin (BSA), 150 mM NaCl, 0.05% (w/v) NaN3, 25 
mM Tris-Cl, pH 7.4 (blocking buffer). The blocking solution was removed, and wells were then 
washed three times with 100l of 150mM NaCl, 25mM Tris-Cl, pH 7.4, and containing 1 mg/ml 
BSA (washing buffer).  Purified 1-Fc was added to the plate incubated at room temperature for 
1 h. Wells were washed three times in washing buffer, and biotin labeled A1-42 (50l, 
monomer, oligomer or fibrils at the indicated concentrations were added for 1h at 37°C. After 
washing wells 3 times in washing buffer, streptavidin-HRP (1:2000 dilution in washing buffer, 
Cell Signaling) was added (50l/well) for 30 min at room temperature. Wells were washed 4x in 
washing buffer, and color was developed using the TMB substrate (Cell Signaling) and read at 
450nM wavelength. Background A binding to conditioned medium from mock-transfected 
CHO cells was subtracted from all measurements (specific binding). 
Mice and Human Samples 
APP/PS1, wild type (WT), Cofilin+/-, and 1-integrin fl/fl mice were all bred in the 
C57BL6 background for at least 3 generations prior to interbreeding with each other. APP/PS1 
mice were obtained from Jackson laboratory (Jankowsky et al., 2004). We generated Cofilin+/- 
knockout mice from an embryonic stem (ES) cell gene trap clone originally made by Lexicon 
Genetics and deposited into the MMRRC repository (UC, Davis). Cofilin+/- mouse brains 
exhibited ~50% reduction in endogenous Cofilin protein in both hippocampus and cortex 
compared to littermate wild type mice (Supplemental Fig. S8). While Cofilin+/- mice were 
viable and fertile with no salient abnormalities, Cofilin+/-X Cofilin+/- crosses yielded no viable 
Cofilin-/- pups (embryonic lethal). Detailed genotypic and phenotypic information about these 
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mice are available (http://www.informatics.jax.org/external/ko/lexicon/2682.html). Information 
on 1-integrin fl/fl mice are also available (http://jaxmice.jax.org/strain/004605.html). Post-
mortem brain samples were obtained from the UC, Irvine, ADRC. Ages, gender, and PMI are 
indicated in Supplemental Fig. S5. 
Immunofluorescence 
Immunohistochemistry and immunocytochemistry were performed as previously 
described (J. A. Woo et al., 2012). Briefly, animals were perfused with 4% paraformaldehyde in 
PBS, and the brains were post-fixed in the same fixative for 24 hr. The brains were then 
cryoprotected in 30% sucrose and sectioned (30 µm) on a cryostat or microtome. For primary 
neurons and HT22 cells, cells were fixed in 4% paraformaldehyde for 15min at room 
temperature. For cell surface protein detection only, Triton-X-100 was omitted. After blocking 
with normal goat serum, primary antibodies were applied overnight at 40C, and secondary 
antibodies were applied for 45min at room temperature, followed by counterstaining with 
Hoechst33342 or DAPI. Immunoreactivities were quantitated from every 12th serial section 
through an entire hippocampus or anterior cortex. In brain, focal Vinculin was separated from 
diffuse cytosolic Vinculin by using the ‘thresholding’ function in Image J software, where the 
threshold was adjusted to convert the highest intensity signal from green to red while not altering 
the diffuse cytosolic Vinculin signal. The average area and size/puncta were quantitated with the 
Image J software. In primary neurons, vinculin immunoreactivity was quantified in dendrites and 
dendritic spines by subtracting diffuse cytosolic intensity in dendrites, which proves an internally 
controlled measure of focal vinculin vs. diffuse cytosolic vinculin.  All images were acquired 
with the Olympus FV10i confocal microscope and quantified using the Olympus Fluoview 
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Software. All comparison images were acquired with identical laser intensity, exposure time, and 
filter. Adjustments to the brightness/contrast were applied equally to all comparison images. 
JC-1, Mitosox-Red, and H2DCF Imaging 
HT22 cells seeded in 24-well plates were treated with/without HUTS-4 (1:250), 
MAB1965 (1:250), or Nox inhibitor III (40nM) for 45min, then treated with or without A42O 
(1M) for 2h. For Mitosox-Red imaging, cells were then washed with PBS and Mitosox-Red 
added to a final concentration 5M in PBS for 15min at 370C, after which cells were washed 
with PBS, fixed, and imaged under the Olympus FV10i confocal microscope. For H2DCF 
imaging, after washing cells in PBS, H2DCF was added at a final concentration of 50nM in 
HBSS for 15min at 370C, followed by live cell imaging at 370C with the Nikon Eclipse Ti 
fluorescence microscope. For JC-1 imaging, after washing cells in PBS, JC-1 was added at a 
final concentration of 0.5M in PBS and incubated for 15min at 370C, followed by live cell 
imaging at 370C with the Nikon Eclipse Ti fluorescence microscope. All comparison images 
were acquired with identical laser or mercury lamp intensity, exposure time, and filter. 
Adjustments to the brightness/contrast were applied equally to all comparison images. 
Stereotaxic Surgery 
Eight-month old APP/PS1 mice were stereotaxically injected with 2l of either control 
IgG (control ascites diluted 1:10 in PBS) into the left hemisphere or 1-integrin neutralizing IgG 
(MAB1965 ascites diluted 1:10 in PBS) into the right hemisphere of the hippocampus (AP 2.7, 
Lat -2.7, DV -3.0) using the convection enhanced delivery method described previously (Carty et 
al., 2010). Forty-eight hours later, mice were subjected to transcardial perfusion with 4% 
paraformaldehyde followed by tissue sectioning and immunohistochemistry.  
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Electrophysiology in Mouse Brain Slices 
Hippocampus slices were prepared from 3-month-old wild type (WT), APP/PS1, and 
APP/PS1;Cofilin+/- mice and subjected to input/output curved, paired pulse facilitation, and 
LTP as previously described (Weeber et al., 2002). Briefly, animals were sacrificed, brains were 
harvested and sectioned horizontally (400 m) in ice-cold cutting solution (110 mM sucrose, 6 
mM NaCl, 3 mM KCl, 26mM NaHCO3, 1.25mM NaH2PO4, 7mM MgCl2, 0.5mM CaCl2, 10g/L 
Glucose, pH 7.3–7.4). The hippocampus was dissected and acclimated in 50:50 solution 
(cutting:artificial cerebrospinal Fluid (ACSF)) for 10 min at room temperature. Then the slices 
were transferred to ACSF (125mM NaCl, 2.5mM KCl, 1.25mM NaH2PO4, 0.26mM NaHCO3, 
1.2mM MgCl2, 2.0mM CaCl2, and 10g/L Glucose, pH 7.3–7.4, saturated with 95% O2 and 5% 
CO2). Slices were recovered in ACSF at room temperature at least 40 min, followed by a final 
incubation in ACSF for 1 hour at 30°C. 
Extracellular field potential recording, LTP: The recording chamber was held at 30 ± 
0.5°C with ACSF flow rate of 1 ml/min.  The stimulating electrode was placed in the Schaffer 
collaterals of the hippocampus. The recording glass electrode loaded with ACSF was positioned 
at the CA1 stratum radiatum below the pyramidal cell layer. Stimulating pulses were generated 
by the Digidata 1322A interface (Molecular Devices, Sunnyvale, CA) and a stimulus isolator 
(model 2200; A-M Systems, Sequim, WA) under control of Clampex 10.0 software (Molecular 
Devices). Field excitatory postsynaptic potentials (fEPSP) were amplified using a differential 
amplifier (model 1800; A-M Systems), filtered at 1 kHz, and digitized at 10 kHz. 
Input-output curve was generated by stepping stimulation amplitude from 1 to 15mV. 
Stimulation amplitude that elicited half-maximal fEPSP was determined by the Input-output 
curve and stimulation rate of 0.05Hz was used through the whole experiment. Paired-pulse 
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facilitation (PPF), which is short-term plasticity, was evoked by two pulses with interpulse 
intervals from 20ms to 300ms. Percentage of the facilitation was calculated by dividing field 
excitatory postsynaptic potential (fEPSP) slope elicited by the second pulse with the fEPSP slope 
elicited by the first pulse.  Long-term potentiation (LTP) was induced by theta burst stimulation 
(TBS) (5 trains of four pulses at 200Hz separated by 200ms, repeated 6 times with an inter-train 
interval of 10 sec). LTP was sampled 60 min after the induction, and calculated by dividing the 
slope of 60 min post-induction responses with the average slope of 20 min baseline responses. 
Fear Conditioning, Open Field, and Rotarod Behavior  
Fear conditioning (contextual & cued), rotarod, and open field tasks were performed as 
previously described (Bolognani et al., 2007). For fear conditioning, an aversive stimulus (in this 
case a mild foot shock, 0.5mA) was paired with an auditory conditioned stimulus (white noise) 
within a novel environment. Training consisted of two mild shocks paired with two conditioned 
stimuli with a 3 min interval between each shock. Freezing on the training day in response to the 
foot shock was used as an estimate of learning during the acquisition trial. To test conditioning to 
the context, animals were re-introduced to the same training chamber for 6 min and freezing 
behavior was recording by tracking software (any-maze) every second. To test conditioning to 
the tone, animals were introduced to a novel context, consisting of a chamber with different 
shape, floor and olfactory cues from the training chamber. Mice were scored for 3 min, before 
and after the tone in the same manner described above. Learning was assessed by measuring 
freezing behavior (i.e. motionless position) every second. The open field was used as a standard 
test of general activity. Briefly, animals were monitored for 15 minutes in a 40 cm square open 
field with a video tracking software (Any-maze). General activity levels were evaluated by 
measurements of total distance traveled and total time immobile. Motor performance was 
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evaluated by an accelerating rotarod apparatus with a 3cm diameter rod starting at an initial 
rotation of 4 RPM slowly accelerating to 40 RPM over 5 minutes. The time spent on the rod 
during each of four trials per day for two consecutive days was measured previously described in 
(Brownlow, Benner, D'Agostino, Gordon, & Morgan, 2013) 
Statistical analysis & graphs 
Statistical data were analyzed by the GraphPad Prizm 6.0 software (GraphPad Software, 
San Diego, CA) using Student’s t-test, 1-way or 2-way ANOVA. One-way or 2-way ANOVA 
was followed by Tukey posthoc test. All quantitative graphs were expressed as mean + SEM. 
Differences were deemed significant when P<0.05.  
Results 
Aβ42O Induces Loss of Cell Surface β1-Integrin but Not TfR or PrP
c and Reduces β1-
Integrin Activation  
We prepared A1-42 oligomers (A42O) as previously characterized (Dahlgren et al., 
2002). These A42O preparations contained SDS-resistant dimers, trimers, and tetramers 
(Supplemental Fig. S2-1A). The indicated A42O concentrations heretofore are based on the 
monomer concentration. To determine whether A42O alters surface levels or activation status of 
1-integrin, we plated the hippocampus-derived HT22 mouse cell line in the presence and 
absence of fibronectin (FN) coating, treated them with A42O for 2 hours and performed cell 
surface biotinylation experiments. Cell surface 1-integrin normalized to total was significantly 
reduced by ~60% regardless of FN coating after A42O treatment without altering total 1-
integrin, although FN coating also significantly increased surface 1-integrin (Fig. 2-1A,B; 
Supplemental Fig. S2-1B,C). While FN coating modestly but significantly increased surface/total 
transferrin receptor (TfR), A42O (1M) had no significant effect on surface TfR (Fig. 2-1A,C). 
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Surface PrPc was unaffected by either FN coating or A42O treatment (Fig. 2-1A,D). In FN-
coated coverslips, A42O (2h) also significantly reduced total surface 1-integrin levels by ~45% 
and further reduced activated surface 1-integrin by ~75% as detected by the HUTS-4 antibody 
(Luque et al., 1996) in non-permeabilized cells (Fig. 2-1E,F). In DIV14 fixed and permeabilized 
neurons, A42O treatment per se significantly reduced the FITC-HUTS-4-positive activated 1-
integrin by >50%, which was significantly prevented by the 1-integrin allosteric modulating 
antibody (MAB1965)(Aljamal-Naylor et al., 2012) and the PrPc function blocking antibody 
(6D11)(Lauren et al., 2009)(Fig. 2-1G,H). 
β1-Integrin Allosteric Modulation or Activation Reduces Aβ42O Binding to Neurons, HT22 
Cells, and Purified β1-Integrin 
We next assessed A42O binding to mature DIV21 hippocampal neurons by adding 
100nM FITC-A42O for 1h at 37
0C with prior incubation (1h) with control IgG, MAB1965, or 
HUTS-4 monoclonal IgGs. As expected, FITC-A42O associated with dendrites and dendritic 
spines, and such binding was significantly reduced by MAB1965 IgG by ~50% (Fig. 2-2A,B). 
The HUTS-4 IgG, which has been shown to enhance ligand binding to 1-integrin(Valdramidou 
et al., 2008), also significantly reduced FITC-A42O binding to neurons by >60% (Fig. 2-2A,B). 
As previously shown(Lauren et al., 2009), 6D11 IgG significantly reduced FITC-A42O binding 
to neurons by ~50% (Fig. 2-2A,B). In 1-integrin fl/fl neurons (conditional knockout, 
cKO)(Raghavan, Bauer, Mundschau, Li, & Fuchs, 2000) transduced with high-titer lentiviruses 
expressing Cre-mRFP, FITC-A42O binding to neurons was significantly reduced by >60% (Fig. 
2-2C,D) while reducing 1-integrin expression by ~80-90% (Fig. 2-2E). We next determined 
whether A binds directly to 1-integrin-Fc (extracellular domain fused with human IgG-
Fc).(Valdramidou et al., 2008) Biotin-A42O bound to purified 1-Integrin-Fc (Fig. 2F) coated 
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on ELISA plates with high affinity in the presence of 5mM MgCl2, which induces an 
intermediate open integrin conformation (Fig. 2-2G, Kd=11.3nM based on monomer calculation). 
In the absence of cation, minimal binding of A42O to 1-integrin-Fc was detected and did not 
appreciably increase with increasing biotin-A42O (Fig. 2-2G).  Surprisingly, MnCl2 (0.5mM), 
which induces the maximal open activation state of integrins(Valdramidou et al., 2008), failed to 
support A42O binding to 1-integrin-Fc (Fig. 2-2G), indicating that A42O prefers an 
intermediate activation state of 1-integrin. Accordingly, FITC-A42O binding to HT22 cells 
was also significantly reduced in the presence of 0.5mM MnCl2 or MAB1965 but not MgCl2 
(Fig. 2-2H,I). Unlike A42O, A42 monomers and fibrils bound poorly to 1-integrin-Fc 
(Supplemental Fig. S2-2). 
Essential Role of β1-Integrin in Aβ42O-induced Cofilin Activation and Reciprocal 
Requirment of Cofilin in Aβ42O-induced Depletion of Surface β1-Integrin and Focal 
Complexes  
A42O (2h, 1M) treatment to primary cortical neurons significantly induced Cofilin 
dephosphorylation/activation (Fig. 2-3A,B). However, such Cofilin dephosphorylation was 
absent in 1-integrin cKO neurons transduced with Lenti-Cre-mRFP (Fig. 2-3A,B). We next 
determined whether Cofilin per se is also required for the observed A42O-induced depletion of 
cell surface 1-integrin in HT22 cells. A42O reduced surface 1-integrin, and Cofilin siRNA 
reduced Cofilin levels (Fig. 2-3C). However, Cofilin siRNA increased surface 1-integrin levels 
and prevented the A42O-induced reduction in surface 1-integrin (Fig. 2-3C). Quantification of 
surface 1-integrin and PrPc levels secondary to Cofilin siRNA demonstrated that Cofilin 
knockdown significantly increases the surface/total 1-integrin ratio without affecting 
surface/total PrPc ratio (Fig. 2-3D,E), similar to that observed with A42O treatment.  
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A direct consequence of 1-integrin internalization is the disruption of Integrin and F-
Actin-associated focal complexes, structurally organized by Talin and Vinculin. We treated 
DIV14 cortical neurons or HT22 cells with or without A42O (1M) and subjected them to 
sequential extraction of the cytosolic fraction on ice with the surfactant saponin, followed by 
extraction of membrane and cytoskeletal elements with SDS sample buffer (FC enriched 
fraction). A42O saliently reduced FC-enriched but not cytosolic (cyto) Vinculin and Talin in 
primary neurons (Supplemental Fig. S2-3A) and HT22 cells (Supplemental Fig. S2-3B,C). To 
observe focal Vinculin in a different way, we cultured primary hippocampal neurons to DIV21 
and treated them with or without A42O for 2 hours followed by staining for Vinculin and F-
Actin. Regardless of A42O treatment, Vinculin nearly completely co-localized with F-Actin, 
and discrete puncta positive for both Vinculin and F-Actin were seen in dendritic spines (Fig. 2-
3F). However, A42O exposure significantly reduced focal Vinculin immunoreactivity in spine-
containing dendrites after subtracting the diffuse cytosolic stain in dendrites (Fig. 2-3F,G). In 7-
month wild type mice, Vinculin immunoreactivity in the CA3 pyramidal neurons demonstrated 
punctate immunoreactivity throughout neuronal cell bodies, indicative of focal complexes, with 
little diffuse staining. However, in 7-month old APP/PS1 transgenic littermates(Jankowsky et al., 
2004), Vinculin immunoreactivity appeared markedly more diffuse and cytosolic in the CA3 
pyramidal neurons (Supplemental Fig. S2-3D)with significant 75% and ~50% reductions in area 
and size of focal Vinculin, respectively, in APP/PS1 mice compared to wild type littermates 
(Supplemental Fig. S2-3E).  
A42O treatment (1M) to wild type neurons depleted focal Vinculin and Talin (Fig. 2-
3H). However, the same treatment in littermate Cofilin+/- neurons did not significantly deplete 
Vinculin and Talin in the FC enriched fraction compared to wild type (WT) neurons (Fig. 2-
 41 
3H,I). Accordingly, Cofilin knockdown also prevented A42O-induced depletion of Focal 
Vinculin in HT22 cells (Supplemental Fig. S2-4A,B).  Next, we stereotaxically injected 8-month 
old APP/PS1 mice hippocampi with 2l 1-integrin allosteric modulating / neutralizing antibody 
(MAB1965 prediluted 1:10) into the right hemisphere and control IgG (control ascites fluid 
prediluted 1:10) into the left hemisphere. Forty-eight hours post-injection, MAB1965 IgG 
significantly increased focal Vinculin area and size in CA3 pyramidal neurons compared to 
control IgG in the contralateral hemisphere (Fig. 2-3J,K), indicating that endogenous 1-integrin 
mediates APP/A-induced depletion of focal Vinculin in brain. 
Essential Roles of Cofilin and β1-Integrin in Aβ42O-Induced Depletion of F-Actin and F-
Actin-Associated Synaptic Proteins in Primary Hippocampal Neurons 
The primary function of Cofilin is to sever F-Actin, which promotes synaptic remodeling 
via accelerating Actin dynamics. (Shirao & Gonzalez-Billault, 2013). As A42O induced Cofilin 
activation, we cultured hippocampal neurons derived from Cofilin+/- and wild type (WT) 
littermate mice and cultured them to DIV21. A42O (1M, 2h) significantly depleted F-Actin, 
Drebrin, and PSD95 in dendritic spines and spine-containing neurites of WT neurons (Fig. 2-
4A,B). However, the same A42O treatment had no significant effects in Cofilin+/- neurons (Fig. 
2-4A,B), indicating that a critical threshold of endogenous Cofilin is required for A42O-induced 
depletion of F-Actin, Drebrin, and PSD95. Likewise, allosteric modulation of 1-integrin with 
MAB1965 IgG completely prevented the depletion of F-Actin and PSD95 induced by A42O 
(Fig. 2-4C,D), indicating that the 1-integrin-Cofilin pathway mediates A42O-induced changes 
in F-Actin and F-Actin-associated postsynaptic proteins. 
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Requriement of Slingshot-1 (SSH1) in Aβ42O-Induced Cofilin Translocation to 
Mitochondria and Accumulation of Mitochondrial Cofilin in AD brains  
Activated and oxidized Cofilin is known to translocate to mitochondria, where it induces 
mitochondrial dysfunction (Klamt et al., 2009; Roh et al., 2013a). We treated HT22 cells with or 
without A42O (1M) for 0, 2, and 4 hours and fractionated intact mitochondria from cytosol. 
A42O rapidly increased the translocation of Cofilin to mitochondria, while decreasing phospho-
Cofilin in the cytosol (Fig. 2-5A, B). No phospho-Cofilin was detected in the mitochondrial 
fraction (Fig. 2-5A), consistent with its activation requirement for translocation. RNAi-mediated 
knockdown of SSH1, the phosphatase that activates Cofilin(Niwa et al., 2002), significantly 
prevented A42O-induced translocation of Cofilin to mitochondria together with increased 
Cofilin phosphorylation (Fig. 2-5C), indicating that A42O activates and promotes Cofilin 
translocation to mitochondria via SSH1. We next isolated mitochondria from the frontal cortex 
of age-matched cognitively normal control (NC) and AD patients (Supplemental Fig S2-5). In 
the absence of DTT in sample buffer (non-reducing), we detected cysteine oxidized Cofilin 
monomers, dimers, trimers, and higher-order oligomers, which essentially all collapsed to the 
monomer form in the presence of DTT (reducing) (Fig. 2-5D). This banding pattern is similar to 
that observed from Cofilin-Actin rods, which also require activation and oxidation-induced 
disulfide bonding to form(B. W. Bernstein et al., 2012). Total Cofilin (all 4 bands in non-
reducing condition), oxidized Cofilin oligomers (dimers or larger), and Cofilin monomers were 
significantly increased in mitochondria of AD (Fig. 2-4D,E), results that fulfill the prediction 
from cultured cells and suggest that activated and oxidized mitochondrial Cofilin plays a 
pathogenic role in AD. 
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Aβ42O-Induced ROS productions, Mitochondrial Dysfunction, and Apoptosis via the 1-
Integrin-SSH1-Cofilin Activation Pathway 
HT22 cells were treated with A42O (1M) with or without vehicle, NOX inhibitor, 
HUTS-4 IgG, or MAB1965 IgG and then subjected to live cell imaging for JC-1, Mitosox-Red, 
and H2DCF. As expected, A42O treatment (1M, 2h) significantly decreased mitochondrial 
membrane potential (increased JC-1 green/red ratio), increased mitochondrial superoxide 
(Mitosox-Red), and increased ROS levels (H2DCF) (Fig. 2-6A,B; Supplemental Fig. S2-6A). 
However, co-incubation with HUTS-4, MAB1965, or NOX inhibitor significantly prevented 
such changes induced by A42O, although the JC-1 membrane potential measure was not fully 
restored by these treatments (Fig. 2-6A,B; Supplemental Fig. 2-S6A). Accordingly, MAB1965 
significantly prevented A42O-induced apoptosis in primary neurons and HT22 cells as assessed 
by Annexin V/PI staining (Supplemental Fig. S2-6B-D). Similarly, Annexin V/PI staining also 
demonstrated significant induction of early (Annexin V) and late (PI) apoptosis after 24h A42O 
(1M) treatment, which was nearly completely blocked by SSH1 siRNA knockdown (Fig. 2-
6C,D), indicating that SSH1-dependent Cofilin activation is required for A42O-induced 
apoptosis.  
A key mechanism of Cofilin regulation is via the binding of SSH1 to 14-3-3, which 
renders SSH1 sequestered in an inactive state. However, the oxidation of 14-3-3 releases SSH1, 
thereby leading to SSH1 activation (Eiseler et al., 2009a; J. S. Kim et al., 2009). In 7-month old 
APP/PS1 mice, SSH1/Cofilin complexes and 14-3-3/SSH1 complexes were significantly 
increased and decreased, respectively, compared to wild type littermate mice (Fig. 2-6E,F), 
indicating the release of SSH1 from 14-3-3 and association of SSH1 with Cofilin in APP/PS1 
mice. Accordingly, phospho-Cofilin was significantly decreased in APP/PS1 mice, despite no 
apparent changes in total 14-3-3, SSH1, or Cofilin in TX-100 solubilized extracts (Fig. 2-6E,F).  
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A42O treatment also reduced 14-3-3/SSH1 complexes in HT22 cells, which was largely 
restored with prior treatment with MAB1965 or the potent anti-oxidant Trolox (Supplemental 
Fig. S2-7B). Likewise, A42O treatment significantly increased SSH1/Cofilin complexes in 
HT22 cells (Supplemental Fig. S2-7C,D). These results therefore demonstrate that APP/A 
promotes Cofilin activation at least in part via the 1-integrin-ROS-14-3-3/SSH1 pathway. 
Cofilin Reduction Rescues APP/Aβ-Induced Gliosis and Loss of Synaptic Proteins as well 
as LTP and Contextual Memory Deficits in APP/PS1 mice  
We examined brains of 7-month old APP/PS1, APP/PS1;Cofilin+/-, and WT littermate 
mice for neurodegenerative phenotypes, including GFAP for astrogliosis as well as PSD95 
(postsynaptic) and Synapsin I (presynaptic) for synaptic integrity. As expected, APP/PS1 mouse 
hippocampi demonstrated significantly increased GFAP immunoreactivity throughout the 
hippocampus as well as diminished Synapsin I and PSD95 immunoreactivity within the stratum 
lucidium (SL: synaptic terminating zone) of CA3 (Fig. 2-7A,B). In contrast, APP/PS1;Cofilin+/- 
mice showed significantly reduced GFAP immunoreactivity and increased Synapsin I and 
PSD95 immunoreactivities compared to APP/PS1 littermate mice, essentially indistinguishable 
from wild type littermates (Fig. 2-7A,B).  
We next tested short-term and long-term synaptic plasticity from acute hippocampal 
slices prepared from 3-month old wild type (WT), APP/PS1, and APP/PS1;Cofilin+/- mice. The 
stimulating electrode was placed in the Schaffer collaterals of the hippocampus, and the 
recording electrode was positioned at the CA1 stratum radiatum below the pyramidal cell layer. 
As shown in Fig. 2-7C, the input-output curves did not markedly differ among WT, APP/PS1, 
and APP/PS1;Cofilin+/- slices. In paired pulse facilitation (PPF) experiments, we observed 
significant differences in fEPSP slope across genotypes among all interstimulus intervals (Fig. 2-
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7D). However, correction for multiple comparisons showed that only APP/PS1;Cofilin+/- and 
WT slices differed significantly at the 40ms interstimulus interval (Fig. 2-7D). For long-term 
potentiation measurements, we detected no differences in fEPSP slope among WT, APP/PS1, 
and APP/PS1;Cofilin+/- slices  at baseline (Fig. 2-7E). However after theta burst stimulation, we 
observed significant differences in fEPSP slope across genotypes for all time points (Fig. 7E). 
Correction for multiple comparisons showed that APP/PS1 slices were significantly impaired in 
fEPSP slope compared to WT and APP/PS1;Cofliln+/- slices at every time point up to 1 hour, 
indicating that Cofilin reduction rescues the deficits in LTP in APP/PS1 mice. 
We carried out fear conditioning tests (contextual & cued), in which 7-month old WT, 
APP/PS1, and APP/PS1;Cofilin+/- mice were trained on day 1 for both. On day 2, we tested 
mice for contextual and cued conditioning memory. We observed no significant differences 
between the genotypes in percent time spent freezing during the training phase (Fig. 2-7F). 
However, we observed significant differences across genotypes in the percentage of time spent 
freezing during the hippocampus-dependent contextual fear conditioning test on day 2. 
Correction for multiple comparisons showed that wild type and APP/PS1;Cofilin+/- mice 
significantly spend more time freezing than APP/PS1 mice (Fig. 2-7G). On the hippocampus-
independent cued fear conditioning test, we did not observe significant differences in the 
percentage of time spent freezing times across genotypes (Fig. 2-7H). We also did not find 
significant differences among the 3 genotypes in the rotarod or open field (total distance traveled 
& total time spent immobile) tests (Fig. 2-7I-K), indicating the absence of salient perturbations in 
generalized motor activity or coordination.  Taken together, these results demonstrate that 
endogenous Cofilin is required to mediate the APP/PS1-induced deficits in synaptic plasticity as 
well as hippocampus-dependent contextual memory but not cued memory. 
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Discussion 
Molecular pathways that govern the production and neurotoxicity of Aβ are attractive 
therapeutic targets for AD. While previous studies have shown Cofilin activation in AD brains 
and potential involvement of 1-integrin in A-induced apoptosis (T. Kim et al., 2013; 
Minamide et al., 2000; Q. Wang et al., 2008b; Wright et al., 2007b), it was unknown whether 
endogenous Cofilin per se and different 1-integrin conformers are required for molecular events 
leading to A42O-induced neurodegeneration and how the 1-integrin-Cofilin signaling pathway 
mediates AD-relevant pathogenic processes.  
In this study, we demonstrated for the first time that A42O induces the depletion of 
surface 1-integrin via its direct binding to low-intermediate activation conformers of 1-
integrin, as detected by competition of A42O binding to neurons and HT22 cells with the 1-
integrin activating antibody (HUTS-4) or MnCl2, both of which induce high conformational 
activation of 1-integrin (Luque et al., 1996; Valdramidou et al., 2008). Moreover, MnCl2 
essentially eliminated Aβ42O binding to purified β1-integrin-Fc. However, A42O did not bind to 
1-integrin-Fc in the absence of Mg2+, suggesting that an intermediate / partially open 
conformation of integrin is required for binding. While physiological ligands bind with high 
affinity to the highly active/open conformation of 1-integrin (Valdramidou et al., 2008), the 
human Ecovirus binds to the relatively inactive/closed integrin conformer (Jokinen et al., 2010), 
similar to what we observed with A42O. This finding raises the intriguing possibility of 
blocking A42O-induced neurotoxic actions by conformational 1-integrin activation without 
compromising integrin function. In addition to preferentially binding to low-intermediate 
activation 1-integrin conformers, A42O also increased the propensity of 1-integrin to assume 
a lower-activation conformation, probably by preventing bound 1-integrin from assuming a 
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high-activation state. As A42O reduced surface 1-integrin levels regardless of FN plating, 
A42O likely does not compete with most physiological ligands (i.e. FN) for integrin binding, as 
seen by its preference for binding to lower-activation conformation of 1-integrin. Although we 
focused on 1-integrin in this study, it is well known that 1-integrin functions in concert with 
various -integrin subunits, such as 2 and αv, which have been shown to be involved in A 
neurotoxicity(Wright et al., 2007b), as well as α6, which has been implicated in microglial 
phagocytosis of fibrillar A together with β1(Koenigsknecht & Landreth, 2004).  
Our observation that the PrPc blocking antibody (6D11) significantly prevented Aβ42O-
induced reduction in β1-integrin activation was somewhat surprising. However, it has been 
reported that PrPc and Pir-B, both of which bind Aβ42O, negatively regulate β1-integrin 
activation and signaling(Loubet et al., 2012; Pereira, Zhang, Takai, & Lowell, 2004), raising the 
possibility that loss of these receptors can also interfere with Aβ42O binding to β1-integrin in 
neurons. These receptors, including β1-integrin are typically clustered in pre- and postsynaptic 
membranes, and their activities are regulated by crosstalk at multiple points of convergence by 
other transmembrane receptors. For example, PrPc-dependent activation of Fyn requires Integrin 
engagement (Pantera et al., 2009), and glutamate signaling via NMDARs and AMPARs depends 
on various Integrin heterodimers (Becchetti et al., 2010). Indeed, β1-Integrin is also enriched in 
dendritic spines and is required for dendrite arborization, maintenance of synapses, and 
LTP(Babayan et al., 2012; Bernard-Trifilo et al., 2005; Chan, Weeber, Kurup, Sweatt, & Davis, 
2003; Warren et al., 2012). In view of these observations, it is plausible that Integrins operate 
physically and/or functionally in concert with other Aβ42O-binding receptors to mediate Aβ42O 
binding and neurotoxicity.  
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Deletion of β1-integrin resulted in the failure of Aβ42O to activate Cofilin. At the same 
time, Cofilin was also required for removal of surface β1-integrin, indicating that Cofilin 
normally plays a role in the trafficking and/or internalization of β1-integrin. As such, we focused 
on β1-integrin and F-Actin-associated structural focal components (Talin/Vinculin) and 
postsynaptic proteins known to function in concert with F-Actin and synaptic remodeling, 
because the direct consequence of β1-integrin internalization is the disruption of the structural 
components of focal complexes (Talin & Vinculin), which anchor the cytoplasmic tail of β1-
integrin to F-Actin. Thus, it is likely that the F-Actin severing activity of Cofilin is responsible 
for the removal β1-integrin from the cell surface and the depletion of focal Talin/Vinculin by 
destabilizing or reducing the F-Actin linkage to β1-integrin, changes which were directly 
analogous to F-Action per se and F-Actin-regulated postsynaptic proteins (Drebrin & PSD95).  
Cofilin activity is associated with dendritic spine growth and shrinkage during LTP and 
LTD, respectively (Chen, Rex, Casale, Gall, & Lynch, 2007; Rex et al., 2009; Zhou, Homma, & 
Poo, 2004), and Cofilin regulates the trafficking of AMPA receptors in dendritic spines(Gu et al., 
2010). Therefore, Aβ42O-induced Cofilin activation and resultant F-Actin 
severing/depolymerization also likely underlies the reduction in F-Actin and synaptic proteins 
(PSD95 & Drebrin), both of which could be antagonized by Cofilin reduction or β1-integrin 
allosteric modulation. β-Arrestin 2 recruits Cofilin to dendritic spines upon NMDA receptor 
activation to control the remodeling of spines, and β-Arrestin 2 knockout neurons are resistant to 
Aβ-induced dendritic spine loss through spatial control of Cofilin activation(Pontrello et al., 
2012). Likewise, Cofilin+/- neurons were resistant to Aβ-induced depletion of postsynaptic 
proteins. In view of these observations, it is plausible that Cofilin reduction prevents the 
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sustained over-activation of Cofilin by Aβ oligomers to mitigate the loss of postsynaptic proteins 
and the deficits in LTP. 
Our findings indicated that Aβ42O-induced and β1-dependent Cofilin activation, 
mitochondrial dysfunction, and apoptosis require endogenous SSH1 at least in part via ROS and 
14-3-3. This is consistent with the induction of ROS production by NADPH oxidases (NOX) via 
Rac1-mediated signaling downstream of integrin(Werner & Werb, 2002), Aβ42O–induced 
Cofilin-Actin pathology via a NOX/PrPc-dependent manner(K. P. Walsh et al., 2014), activation 
of SSH1 by oxidation of 14-3-3(J. S. Kim et al., 2009), Aβ-induced oxidation of 14-3-3(Boyd-
Kimball et al., 2005; Sultana et al., 2006), and Cofilin-dependent mitochondrial dysfunction 
downstream of oxidative stress(Roh et al., 2013a). Although a recent study reported that fibrillar 
Aβ42 can activate LIMK1 via PAK1, they also observed increased Cofilin dephosphorylation; 
therefore, Aβ oligomers and fibrils may impact the Cofilin activation pathway via similar but 
also divergent mechanisms(Mendoza-Naranjo et al., 2012). In addition to ROS-dependent 
activation of SSH1, it is likely that Aβ42O can also activate Cofilin via a mechanism involving 
an increase in cytosolic Ca2+, which in part may be mediated by the PrPc-mGluR5 complex(Um 
et al., 2013), as Calcineurin dephosphorylates and activates SSH1(Y. Wang et al., 2005a). We 
have also shown that RanBP9, which activates Cofilin, also impairs mitochondrial Ca2+ buffering 
and mitochondrial homeostasis in a Cofilin-dependent manner (Liu, Roh, Woo, Ryu, & Kang, 
2013; Roh et al., 2013a; J. A. Woo et al., 2012).  
Conclusion 
Our findings indicate that a molecular pathway involving SSH1-Cofilin activation via 
direct engagement of lower-activation conformers of 1-integrin is essential for both A42O-
induced mitochondrial and synaptic dysfunction in AD. Therefore, promoting 1-integrin 
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activation and/or inhibiting excessive Cofilin activation (i.e. SSH1 inhibition) represent 
potentially viable and novel therapeutic strategies to combat AD pathogenesis. 
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Figure 2-1. Aβ42 oligomers induces loss of cell surface β1-integrin but not TfR or PrPc and reduces β1-
integrin activation 
a-d) HT22 cells plated with/without Fibronectin with/without Aβ42 oligomers (1µM, 2hours), subjected to surface biotinylation 
(surface), and direct immunoblotting (total) or immunoprecipitation for biotin (surface) and immunoblotting for the indicated 
protein.  b-d) Quantification of normalized surface/total β1, TfR, and PrPc (n>3 replicates, ANOVA, post hoc Tukey, *p<0.05, 
#p<0.005). Error bar represent S.E.M. e & f) HT22 cells treated with/without Aβ42 oligomers and immunostained for total 
surface β1-integrin or activated surface β1-integrin without membrane permeabilization (n>4 replicates, T-test, **P<0.005, 
#P<0.005). g & h) Direct staining for activated β1-integrin (FITC-HUTS-4 antibody) in fixed and permeabilized DIV14 primary 
hippocampal neurons after treatment with/without Aβ42 oligomers (1µM, 2 hours) and/or control ascites IgG (1:250), MAB1965 
(1:250), or 6D11 (1:50). H) Quantification of FITC-HUTS-4 immunoreactivity (n=4 replicates, ANOVA, post 
hocTukey,*P<0.05, **P<0.005). 
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Figure 2-2. β1-Integrin allosteric modulation or activation reduces Aβ42 oligomers binding to neurons, HT22 
cells, and purified β1-integrin as effectively as the loss of β1-integrin 
a & b) FITC-Aβ42O (100 nM, 1 hour) binding to DIV21 primary hippocampal neurons with/without prior treatment (1 h) of 
control IgG, MAB1965 (β1-integrin allosteric modulator, 1:250), HUTS-4 (β1-integrin allosteric activator, 1:250), and/or 6D11 
(PrPc blocking, 1:50) monoclonal antibodies. Bottom panel magnified from regions of white rectangles. b) Quantification of 
FITC-Aβ42 oligomers binding (n>5 replicates, ANOVA, post hoc Tukey, #P<0.0005 compared with control IgG). Error bars 
represent S.E.M. c-e) FITC-Aβ42 oligomers (100 nM, 1 hour) binding to β1-integrin fl/fl neurons transduced with Lenti-mRFP 
(cont) or Lenti-Cre-mRFP (β1 cKO). d) Quantification of FITC-Aβ42O binding (n= 5 replicates,T-test, #P<0.0005). e) 
Representative blots of β1-integrin from cKO (Lenti-Cre-mRFP) versus cont (Lenti-mRFP) neurons (all neurons including 
nontransduced). f) Conditioned medium from CHO cells transfected with β1-integrin-Fc affinity purified with anti-Fc affinity 
column, sequentially eluted, and immunoblotted with anti-Fc. g) Purified β1-integrin-Fc from fractions 1 and 2 captured by 96-
well plates coated with anti-Fc IgG, subjected to biotin-Aβ42 oligomers binding and/or incubated with different cations (MgCl2, 
5mM and MnCl2, 0.5mM). h) Kd= 10.3 nM with MgCl2. Two-way ANOVA, post hoc Bonferroni, n=4 replicates, #P<0.0005. h 
& i) HT22 cells treated with FITC-Aβ42 oligomers (0.1μM, 2 hours) and/or β1-integrin blocking IgG (MAB1965, 1:500), MnCl2 
(0.5mM), or MgCl2 (5mM), and subjected fluorescence microscopy. (h) Representative images of FITC-Aβ42 oligomers 
binding/uptake show inhibition by MAB1965 antibody and MnCl2. i) Quantification of mean intensities of FITC-Aβ42 
oligomers binding/uptake (n= 4 replicates, ANOVA, post hoc Tukey, **P<0.005 compared with FITC-Aβ42 oligomers alone). 
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Figure 2-3. Essential role of β1-integrin in Aβ42 oligomer-induced Cofilin activation as well as reciprocal 
requirement of Cofilin in Aβ42 oligomer-induced depletion of surface β1-integrin and F-actin-associated FCs 
(Vinculin and Talin) 
a & b) DIV14 cortical WT or β1-integrin cKO neurons (transduced with Lenti-Cre) treated with/without Aβ42 oligomers (1μM, 
2 hours) and subjected to immunoblotting. Note the decrease in p-Cofilin by Aβ42 oligomers in WT but not in β1 cKO neurons 
(n=4 replicates, T-test, *P<0.05). Error bars represent S.E.M. c) HT22 cells transfected with control or Cofilin siRNA, treated 
with Aβ42 oligomers (1 μM, 2 hours) and subjected cell surface biotinylation followed by direct immunoblotting or IP with anti-
biotin and immunoblotting. Note that Cofilin knockdown prevents Aβ42 oligomers-induced depletion of surface β1-integrin. d & 
e) HT22 cells transfected with control or Cofilin siRNA and subjected to cell surface biotinylation followed by direct 
immunoblotting or IP with anti-biotin and immunoblotting. d) A representative experiment showing a dramatic increase in 
surfaceβ1-integrin but no change in surface PrPc after Cofilin knockdown. e) Quantification of β1-integrin normalized to total β1-
integrin and surface PrPc normalized to total PrPc (n=4 replicates, T-test, #P<0.0005). f&g) DIV21 hippocampal primary neurons 
treated with/without Aβ42 oligomers (1μM, 2 hours) and subjected to staining for Vinculin, F-actin (rhodamine-phalloidin), and 
DAPI. g) Quantification of focal Vinculin mean intensity (FC Vinculin) in dendrites and dendritic spines after subtracting the 
mean diffuse cytosolic intensity in dendrites (n=5 replicates,T-test, #P<0.0005). Error bars represent S.E.M. h & i) DIV14 cortical 
WT and Cofilin+/− neurons treated with/without Aβ42 oligomers (1μM), subjected to separation of cytosol and FC-enriched 
fractions followed by immunoblotting. h) Aβ42 oligomers-induced depletion FC Vinculin and Talin in WT but not in Cofilin
+/− 
neurons. i) Quantification of FC Vinculin and Talin after 2 hours Aβ42 oligomers treatment normalized to respective vehicle 
treated controls at 100%. (n=3 replicates, T-test,*P<0.05,**P<0.01). j&k) Eight-month-old APP/PS1 transgenic mice and their 
nontransgenic littermates (WT) stereotaxically injected with 2 μl β1-integrin blocking antibody (MAB1965, diluted 1 : 10) into 
the left hippocampus and 2 μl control IgG (control ascites fluid, diluted 1 : 10) into the right hippocampus and subjected to 
immunohistochemistry for Vinculin 48 hours post injection. j) Representative images of Vinculin FCs (red) in the CA3 of the 
hemisphere injected with β1-integrin blocking antibody compared with the control IgG injected contralateral hemisphere.. k) 
Quantification of focal Vinculin area and size normalized to control IgG (n=5 mice, 2 M and 3 F,T-test, **P<0.005). 
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Figure 2-4. Essential roles of Cofilin and β1-integrin in Aβ42 oligomer-induced depletion of F-actin and 
associated synaptic proteins in primary hippocampal neurons 
a & b) WT and Cofilin+/− DIV21 hippocampal neurons treated with/without Aβ42 oligomers (1 μM, 2 hours) and stained for F-
actin (rhodamine-phalloidin), Drebrin, or PSD95. b) Quantification of mean intensities of Drebrin, PSD95, and F-actin in spine-
containing neurites (n =4–6 replicates, ANOVA, post hoc Tukey, *P<0.05, **P<0.005, #P<0.0005). Error bars represent S.E.M. 
c & d) DIV21 hippocampal neurons treated with/without Aβ42 oligomers (1 μM, 2 h) and/or control IgG or β1-integrin IgG 
(MAB1965) and stained for PSD95 and F-actin (rhodamine-phalloidin). c) Representative images showing depletion of PSD95 
and F-actin after Aβ42 oligomers treatment, which is prevented by MAB1965. d) Quantification of mean PSD95 and F-actin 
intensities in spine-containing neurites (n>6 replicates, ANOVA, post hoc Tukey, *P<0.05, **P<0.005) 
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Figure 2-5. Requirement of Slingshot-1 (SSH1) in Aβ42 oligomer-induced Cofilin translocation to 
mitochondria and accumulation of mitochondrial Cofilin in AD brains.  
a & b) HT22 cells treated with/without Aβ42 oligomers (1 μM) for the indicated times and subjected to separation of 
mitochondria and cytosol fractions followed by immunoblotting for the indicated proteins. a) Representative blots showing 
Cofilin dephosphorylation (cytosol) and translocation to mitochondria (mito) after Aβ42 oligomers treatment. b) Quantification 
of cytosolic and mitochondrial Cofilin (n=4 replicates, T-test, **P<0.005, #P<0.0005). c) HT22 cells transfected with control or 
SSH1 siRNA, treated with/without Aβ42 oligomers (1 μM, 4 hours), and subjected to separation of cytosol versus mitochondria 
followed by immunoblotting for the indicated proteins. Note that SSH1 siRNA prevents Aβ42 oligomers-induced Cofilin 
dephosphorylation and translocation to mitochondria (n=4 replicates, ANOVA, post hoc Tukey, #P<0.0005). d & e) 
Mitochondria isolated from mid-frontal cortex of AD (n=5) and cognitively NC (n=4) and immunoblotted for Cofilin and 
Timm50 with or without DTT in sample buffer. d) Representative blots showing abundance of Cofilin monomers (CofM), dimers 
(CofDi), trimers (CofTri), and high molecular weight species (CofH) in AD (blot on left run without DTT). Samples with asterisk 
(*) run with DTT and boiling show reduction of oxidized Cofilin oligomers to collapsed monomers (blot on right). e) 
Quantification of Cofilin total (all four Cofilin bands), oligomers (CofDi, CofTri, and CofH), and monomers (CofM). 
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Figure 2-6 Aβ42 oligomer-induced ROS production, mitochondrial dysfunction, and apoptosis via the β1-
integrin–SSH1–Cofilin activation pathway 
a & b) HT22 cells treated with vehicle or Aβ42 oligomers (1 μM) for 2 hours with or without 1 hour prior treatment with Nox 
inhibitor (VAS2870, 40 nM), HUTS-4 (β1-integrin allosteric activating IgG, 1:250), or MAB1965 (β1-integrin allosteric 
modulating IgG, 1:250) and subjected to live-cell imaging for JC-1 (mitochondrial membrane potential, green/red ratio), 
Mitosox-Red (mitochondrial superoxide indicator), or H2DCF (general ROS indicator). Note that β1-integrin conformational 
modulation or inhibition of Nox significantly reduces Aβ42 oligomers-induced mitochondrial dysfunction and overall ROS 
increase. b) Quantification of JC-1 green/red ratio, Mitosox-Red, and H2DCF intensities (n=6, 1-way ANOVA, post hoc Tukey, 
*P<0.05, **P<0.01, or #P<0.005 compared with Aβ42 oligomers. c & d) HT22 cells transiently transfected with control or 
SSH1 siRNA, treated with / without Aβ42 oligomers (1 μM, 18 hours) in 1% FBS medium, and subjected to FITC Annexin 
V/propidium iodide (PI) staining and fluorescence confocal microscopy. c) Representative images showing reduction in Annexin 
V (early apoptosis) and PI (late apoptosis) staining in cells transfected with SSH1 siRNA (with Aβ42 oligomers). d) 
Quantification of Annexin V/PI staining (n=4 replicates, ANOVA, post hoc Tukey, *P<0.05, **P<0.005, #P<0.0005). e & f) 
Seven-month-old WT and APP/PS1 littermate mouse frontal cortex homogenates (1% Triton X-100) immunoprecipitated for 
pan-14-3-3 or SSH1 and immunoblotted for SSH1 or Cofilin. Same brain samples also directly immunoblotted for the indicated 
proteins. e) Representative blots showing decreased 14-3-3/SSH1 complex and increased SSH1/Cofilin complex in APP/PS1 
mice. f) Quantification of SSH1/14-3-3 complex, Cofilin/SSH1 complex, p-Cofilin, and total Cofilin (n=4 mice/genotype, T-test, 
*P<0.02, **P<0.005) 
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Figure 2-7 Cofilin reduction rescues APP/Aβ-induced gliosis and loss of synaptic proteins as well as LTP and 
contextual memory deficits in APP/PS1 mice 
a & b) Seven-month-old WT, APP/PS1, and APP/PS1;Cofilin+/− mice immunostained for GFAP, Synapsin I, and PSD95. a) 
Representative images showing that Cofilin reduction ameliorates astrogliosis and synaptic damage associated with APP/PS1 
mice. b-d) Quantification of mean PSD95 and Synapsin I intensities in the stratum lucidum (SL) (n=4 mice/genotype, ANOVA, 
post hoc Tukey, *P<0.05, #P<0.0005). c-e) Stimulating electrode placed in the Schaffer collaterals of the hippocampus and 
recording glass electrode positioned at the CA1 stratum radiatum below the pyramidal cell layer. c) Input/output analysis 
generated by stepping up stimulation amplitude from 1 to 15mV in WT, APP/PS1, and APP/PS1;Cofilin+/− acute slices. No 
significant differences observed (n= 24 slices from four mice, APP/PS1: 19 slices from four mice, APP/PS1;Cofilin+/−: n=20 
slices from three mice). d) PPF showing no significant differences across genotypes and interstimulus interval except between 
APP/PS1;Cofilin+/− and WT slices at the 40-ms interstimulus interval (two-way ANOVA, post hoc Bonferroni, *P<0.05; WT: 
n=32 slices from four mice, APP/PS1: n= 31 slices from four mice, APP/PS1;Cofilin+/−:n=25 slices from three mice). e) LTP 
induced by the TBS showing significant differences in fEPSP slope in APP/PS1 compared with WT and APP/PS1;Cofilin+/− 
slices (two-way ANOVA, post hoc Bonferroni, P<0.0001 at all-time points). (WT: n= 28 slices from four mice, APP/PS1: n =33 
slices from four mice, APP/PS1;Cofilin+/−: n=20 slices from three mice). Error bars represent S.E.M. f) Percentage of time spent 
freezing during training period on day 1 (no significant differences observed by one-way ANOVA or Kruskal–Wallis statistic; 
WT n=12, APP/PS1 n= 8, APP/PS1;Cofilin+/− n=6; equal distribution of gender). Error bars represent S.E.M. (2-7G) Percentage 
of time spend freezing during contextual fear conditioning (FC) on day 2 (Kruskal–Wallis statistic=9.66, P= 0.008, genotypes= 3, 
values=26; post hoc Dunn’s,*P<0.05; WT n=12, APP/PS1 n=8, APP/PS1;Cofilin+/ − n=6; equalized distribution of gender). h) 
Percentage of time spent freezing during cued fear conditioning (FC) freezing on day 2 (no significant differences observed by 
one-way ANOVA or Kruskal–Wallis statistic; WT n=12, APP/PS1 n =8, APP/PS1;Cofilin+/− n=6; equalized distribution of 
gender). i) Total time spent on rotarod test (no significant differences observed by one-way ANOVA or Kruskal–Wallis statistic; 
WT n= 11, APP/PS1 n=7, APP/PS1;Cofilin+/− n= 5; equalized distribution of gender). j) Total distance traveled during open-
field test (no significant differences observed by one-way ANOVA or Kruskal–Wallis statistic; WT n=11, APP/PS1 n=7, 
APP/PS1;Cofilin+/− n= 5; equalized distribution of gender). k) Total time spent immobile during open-field test (no significant 
differences observed by 1-way ANOVA or Kruskal–Wallis statistic; WT n=11, APP/PS1 n= 7, APP/PS1;Cofilin+/− n=5; 
equalized distribution of gender)  
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Supplementary Figure 2-1 A42O Induces Loss of Cell Surface 1-Integrin 
A) Immunoblotting of unconjugated and FITC-conjugated A42M (freshly solubilized monomer) and A42O (oligomer) 
preparations. Note that A42O run as monomers, dimers, trimers, and tetramers on SDS-PAGE. 
B&C) HT22 cells (without FN coating) treated with or without or without A42O (1M) for 2h and subjected to cell surface 
biotinylation and detection of surface 1-integrin (upper panel). Total 1-integrin without immunoprecipitation (lower panel). B) 
Quantitation of surface 1-integrin normalized to total 1-integrin (n=5 replicates, ANOVA, posthoc Tukey, **P<0.005). Error 
bars represent SEM. 
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Supplementary Figure 2-2 A42 Oligomers but not Monomers or Fibrils Bind to Purified 1-integrin-Fc 
Purified 1-integrin-Fc from fractions 1 & 2 (Fig. 2F)  captured by 96-well plates coated with anti-Fc IgG, subjected to binding 
to biotin-A42O (oligomer), biotin-A42M (monomer), or biotin-A42F (fibril) in the presence of 5mM MgCl2. 2-way ANOVA 
posthoc Bonferroni, n=4 replicates, #P<0.0005.  
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Supplementary Figure 2-3 A42o Disrupt Integrin-dependent Focal Complexes in HT22 Cells, Primary 
Neurons, and APP/PS1 Mouse Brains 
A) DIV14 primary cortical neurons treated with or without 1M A42o for 2h, subjected to sequential extractions with saponin 
(cytosol) and 2x SDS sample buffer (FC), followed by immunoblotting for the indicated proteins. B,C) HT22 cells treated with 
A42o (0, 0.25, & 2M) for 0, 2, or 4h, and subjected to sequential extraction with saponin (cytosol) and lysis with 2x SDS 
sample buffer (FC), followed by immunoblotting for the indicated proteins. C) Quantification of FC Vinculin (n=3 replicates, 
ANOVA, posthoc Tukey, *P<0.05, **P<0.005 compared to control). F,G) Brains from 7-month old APP/PS1 mice and their wild 
type littermates subjected to immunohistochemistry for Vinculin. F) Representative images from the CA3 region of the 
hippocampus. Note that Vinculin appears as focal complexes (red) with little cytoplasmic staining in nontransgenic (WT) mice, 
whereas Vinculin focal complexes and diffuse cytoplasmic staining are decreased and increased, respectively, in APP/PS1 mice. 
Focal Vinculin signal is threshold adjusted to convert highest intensity signals from green to red puncta without altering diffuse 
cytosolic signal. G) Quantification of area covered by focal Vinculin and average size of focal Vinculin in the CA3 of APP/PS1 
and WT mice (n=4 mice/genotype, 2F & 2M, T-test, *P<0.05).  
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Supplementary Figure 2-4 Cofilin Mediates A42O-induced Depletion of Focal Vinculin in HT22 Cells 
A,B) HT22 cells transfected with control or Cofilin siRNA, treated with A42o (1M, 2h) and subjected to sequential extractions 
with saponin (cytosol) and 2x SDS sample buffer (FC), followed by immunoblotting for the indicated proteins. B) Quantification 
showing Cofilin knockdown abrogates A42o-induced depletion of FA Vinculin (n=4 replicates, ANOVA, posthoc Tukey, 
**P<0.005 compared to control). 
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Supplementary Figure 2-5 AD and Control Subject Information 
Information on gender, ages, and post-mortem intervals (PMI) of cognitively normal controls (NC) and AD brain samples (mid-
frontal gyrus). All NC and AD cases are of Caucasian ethnicity. 
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Supplementary Figure 2-6 Allosteric Modulation of 1-Integrin Rescues A42O-induced Apoptosis in Primary 
Neurons and HT22 Cells 
A) HT22 cells HT22 cells treated with vehicle or A42O (1M) for 2h with or without 1h prior treatment with Nox inhibitor 
(VAS2870, 40nM), HUTS-4 (1-integrin allosteric activating IgG, 1:250), or MAB1965 (1-integrin allosteric modulating IgG, 
1:250) and subjected to live cell imaging for H2DCF (general ROS indicator). Representative images show that 1-integrin 
conformational modulation or inhibition of Nox reduces A42O-induced overall ROS increase. Quantifications shown in main 
manuscript Fig. 6B. B,C) DIV14 hippocampal primary neurons treated with or without 1M A42O and 1-integrin allosteric 
modulating and neutralizing IgG (MAB1965; 1:500) for 18 hours under regular culture condition, followed by Annexin V/PI 
staining on glass coverslips. B) Quantification of Annexin V-positive (early apoptotic) and Annexin V/PI-positive (late apoptotic) 
neurons (n=4 replicates, ANOVA, posthoc Tukey, *P<0.05). D) HT22 cells serum starved (1% FBS) for 24h and treated with or 
without A42O (1M) and/or allosteric 1-integrin modulating / neutralizing IgG (MAB1965, 1:500) for 24h. Cells were then 
subjected to propidium iodide (PI) and Annexin V staining followed by FACS analysis. Lower right (Annexin V+) and upper 
right quadrant (Annexin V/PI+) indicate early apoptotic and late apoptotic cells, respectively. A representative experiment from 3 
independent experiments is shown. 
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Supplementary Figure 2-7 A42O Reduces 14-3-3/SSH1 Complex and Increases SSH1/Cofilin Complex in 
HT22 Cells 
A) HT22 cell lysates immunoprecipitated with anti-mouse IgG agarose beads alone or together with pan-14-3-3 monoclonal 
antibody and subjected to immunoblotting for SSH1. Note that SSH1 co-immunoprecipitates with 14-3-3 but not with anti-mouse 
IgG beads alone. B) HT22 cells treated with/without A42
O
 (1M, 2h) and with/without prior treatment (30min) with vehicle 
(DMSO), MAB1965 (1:250), or the antioxidant Trolox (200M). Lysates subjected to direct immunoblotting or IP with pan-14-
3-3 antibody followed by immunoblotting. Note that A42O reduces the 14-3-3/SSH1 complex, which is prevented by MAB1965 
IgG and Trolox. C&D) HT22 cells treated with/without A42
O
 (1M, 2h) and lysates subjected to IP with anti-rabbit agarose 
beads alone or together with anti-SSH1 antibody. Note that Cofilin co-IPs with SSH1 specifically, and the Cofilin/SSH1 complex 
is increased with A42O treatment. D) Quantification of SSH1/Cofilin complex (n=3 replicates, T-test, **P<0.005). 
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Supplementary Figure 2-8 Reduction in Cofilin Protein in the Hippocampus and Cortex of Cofilin+/- Mice 
with No Apparent Abnormarmalities in Gliosis or Synaptic Proteins.  
A) Brains from 6-month old Cofilin+/- and littermate mice were dissected and subjected to immunoblotting for Cofilin and Actin 
from hippocampal (HIPPO) and cortical (CTX) brain extracts. B) Seven-month old WT and Cofilin+/- littermate mice subjected 
to immunohistochemistry for GFAP, PSD95, and Synapsin I. Representative images show no apparent abnormalities in gliosis or 
synaptic integrity. 
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CHAPTER 3 
 
RANBP9 AT THE INTERSECTION BETWEEN COFILIN AND AMYLOID BETA 
PATHOLOGIES   
Permissions Statement 
The information in chapter 3, “RanBP9 at the intersection between Cofilin and Amyloid 
β pathologies” has been legally reproduced under the Creative Commons Attribution (CC-BY) 
license. This means the publication is accessible online without any restrictions and can be re-
used in any way subject only to proper citation.  
 
Woo, J. A., Boggess, T., Uhlar, C., Wang, X., Cappos, G., Joly-Amado, A., Majid, S., Minamide, 
L. S., Bamburg, J. R., Morgan, D., Kang, D. E (2015). “RanBP9 at the intersection 
between cofilin and Aβ pathologies: rescue of neurodegenerative changes by RanBP9 
reduction.” Cell death and disease (2015) 6, 1676; dio:10.1038 
 
Background 
The defining pathological hallmark of Alzheimer’s disease (AD) is the accumulation of 
A in brain associated with tau pathology, synapse loss, cytoskeletal aberrations, mitochondrial 
dysfunction, and cognitive decline. The generation of A occurs via sequential- and -secretase 
processing of the Amyloid Precursor Protein (APP) by BACE1 and the Presenilin complex, 
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respectively(De Strooper & Annaert, 2000b). Soluble oligomeric forms of A are thought to be 
the most toxic species, resulting in synaptic loss and downstream neurotoxicity (D. M. Walsh et 
al., 2002). Despite the requirement for Tau in multiple aspects of A-induced neurotoxicity 
(Morris, Maeda, Vossel, & Mucke, 2011), a large knowledge gap exists as to how the A 
oligomer-induced neurotoxic signals are transduced intracellularly to impair synaptic plasticity, 
eventually leading to neurodegeneration. Both Aand Tau promote Cofilin-Actin pathology (B. 
W. Bernstein & J. R. Bamburg, 2010; Fulga et al., 2007), Cofilin-Actin pathology is widespread 
in AD brains(Minamide et al., 2000), and Cofilin activity is also increased in AD brains(T. Kim 
et al., 2013). Cofilin normally functions as a key regulator of Actin dynamics that destabilizes F-
Actin. Cofilin is inactivated by phosphorylation on Ser3 by LIMK1, whereas its 
dephosphorylation by SSH1 activates Cofilin(B. W. Bernstein & J. R. Bamburg, 2010). Upon 
oxidative stress and/or Ca2+ elevation(B. W. Bernstein & J. R. Bamburg, 2010; J. S. Kim et al., 
2009; Roh et al., 2013a), SSH1 is activated and active Cofilin becomes oxidized on cysteine 
residues, resulting in rapid mitochondrial translocation to promote apoptosis and induction of 
Cofilin-Actin pathology(B. W. Bernstein et al., 2012; Klamt et al., 2009). An early and 
consistent impairment secondary to A oligomer treatment in primary neurons is the shrinkage 
of dendritic spines(Selkoe, 2008) involving the rearrangement of F-actin cytoskeleton in spines 
and loss of spine-associated proteins such as PSD95 and Drebrin(G.M. Shankar et al., 2007; 
Zhao et al., 2006), as well as impaired mitochondrial function(Du et al., 2010; Moreira et al., 
2001).  
We recently found that overexpression of the scaffolding protein RanBP9 increases A 
production in cell lines and in transgenic mice(M.K. Lakshmana et al., 2012; Lakshmana et al., 
2009). Moreover, RanBP9 is significantly increased in brains of AD patients and the J20 APP 
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transgenic model(M.K. Lakshmana et al., 2012; J. A. Woo et al., 2012). In studying the 
trafficking of APP, we also found that RanBP9 overexpression not only promotes the 
endocytosis of APP but also those of LRP and 1-integrin, the latter resulting in disassembly of 
Integrin-associated focal complexes (Talin & Vinculin)(Woo, Roh, Lakshmana, & Kang, 2012). 
In addition, RanBP9 overexpression promotes Cofilin activation and the translocation of Cofilin 
to mitochondria, resulting in overall mitochondrial dysfunction(Roh et al., 2013a; J. A. Woo et 
al., 2012). However, how RanBP9 activates Cofilin is unknown, and it is not clear whether 
reduction in endogenous RanBP9 protects against A oligomer-induced deficits in synaptic 
plasticity, Cofilin-dependent pathology, A accumulation, and memory impairment. Here we 
report that siRNA or genetic reduction in RanBP9 significantly reduces SSH1 levels and 
mitigates A-induced translocation of Cofilin to mitochondria, Cofilin-Actin rod/aggregate 
formation, and depletion of synaptic proteins, deficits in synaptic plasticity, A accumulation, 
and contextual memory deficits in vivo. 
Methods 
Cells, cDNA constructs, siRNA sequences, and transfection 
Hippocampus-derived HT22 cells were maintained in Dulbecco’s modified Eagle's 
medium containing 10% FBS. HT22 cells were obtained from Professor David Schubert (Salk 
Institute, San Diego, CA, USA). The RNAi targeting RanBP9 (5 ′ -
UCUUAUCAACAAUACCUGC-3′) and SSH1 (5′-GAGGAGCUGUCCCGAUGAC-3 ′) were 
obtained from GE Dharmacon (Lafayette, CO, USA). All cells were transfected for 48 h using 
lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s 
instructions with siRNA duplexes or control single-stranded denatured control siRNAs before 
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performing biochemical and/or immunocytochemical assays. All siRNAs were transfected at a 
final concentration of 100 nM. Cortical and hippocampal primary neurons were derived from 
postnatal day 0 (P0) pups and grown on poly-D-lysine-coated coverslips or plates as previously 
described.19 Quantitation of digitized immunoblotting data was performed using the Image J 
software (NIH Image J, Bethesda, MD, USA).  
Antibodies, reagents, and Aβ oligomer preparation 
Antibodies to APP (6E10, Covance, Madison, WI, USA), cofilin (D3F9, Cell Signaling, 
Danvers, MA, USA), phospho-cofilin (77G2, Cell Signaling), actin (AC-74, Sigma Aldrich, St. 
Louis, MO, USA), tubulin (TU-02, Santa Cruz Biotechnology, Dallas, TX, USA), Aβ (D54D2, 
Cell Signaling), GFAP (Invitrogen), synapsin I (Invitrogen), PSD95 (Abcam, Cambridge, MA, 
USA), Drebrin (Abcam), microtubule-associated protein 2 (Millipore, Billerica, MA, USA), 
HRP-linked secondary antibodies (Jackson Immunochemicals, West Grove, PA, USA), and 
fluorescently labeled secondary antibodies (Invitrogen) were obtained from the indicated 
sources. The mouse monoclonal anti-RanBP9 antibody was a generous gift from Professor 
Elizabetta Bianchi (Pasteur Institute, France). Synthetic Aβ1-42 peptide was purchased from 
American Peptide (Sunnyvale, CA, USA). Aβ1-42 oligomers were prepared as previously 
characterized. Briefly, Aβ1-42 powder wasdissolved in hexafluoro-2-propanol (HFIP) at 1 mM 
for 30 min at room temperature, aliquoted to eppendorf tubes, allowed to evaporate overnight in 
fume hood, and subjected to speed vacuum for 1 hour to remove traces of HFIP or moisture. To 
prepare Aβ oligomers, Aβ1-42 film was then dissolved in dimethyl sulfoxide (5 mM), and F-12 
cell culture medium (without phenol) was added to a final concentration of 100 μM Aβ1-42 and 
incubated at 4 °C for 24 hours. 
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Cell/tissue lysis and immunoblotting     
Cultured cells or brain homogenates were lysed with lysis buffer (50 mM Tris-Cl, 150 
mM NaCl, 2 mM EDTA, and 1% Triton X-100) unless stated otherwise. For separation of 
cytosolic versus focal adhesion-enriched (F) fractions, cytosolic proteins were first released with 
saponin buffer (0.1% saponin, 25 mM HEPES, and 75 mM potassium acetate) for 10 min on ice 
followed by extraction of remaining proteins by 2 × SDS sample buffer and sonication. For 
isolation of mitochondria, mitochondrial isolation kit (Thermo Scientific, Rockford, IL, USA) 
was used according to the manufacturer’s instructions for cultured cells. Protein quantification 
was performed by a colorimetric detection reagent (BCA protein assay, Pierce, Rockford, IL, 
USA). Equal amounts of protein were subjected to SDS-PAGE and transferred to nitrocellulose 
membranes for immunoblotting. After probing with the primary antibody, the corresponding 
peroxidase-conjugated secondary antibody was detected by ECL western blot reagents (Pierce). 
ECL images were captured by the Fuji LAS-4000 imager (LAS-4000, Pittsburgh, PA, USA) and 
quantified using the ImageJ software (NIH ImageJ, Bethesda, MD, USA). 
Mice  
APP/PS1, WT, and RanBP9+/− mice19 were all bred in the C57BL6 background for at 
least three generations before interbreeding with each other. APP/PS1 mice, which express 
‘Swedish’ APP and PS1 ΔE9 mutations, were obtained from Jackson Immunoresearch (West 
Grove, PA, USA). 
Immunofluorescence   
Immunohistochemistry and immunocytochemistry were performed as previously 
described. Briefly, animals were perfused with 4% paraformaldehyde in PBS, and brains were 
post-fixed in the same fixative for 24 hours. The brains were then cryoprotected in 30% sucrose 
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and sectioned (30 μm) on a cryostat or microtome. For primary neurons and HT22 cells, cells 
were fixed in 4% paraformaldehyde for 15 min at room temperature. After blocking with normal 
goat serum, primary antibodies were applied overnight at 4 °C, and secondary antibodies were 
applied for 45 min at room temperature, followed by counterstaining with Hoechst33342 or 
DAPI and mounting. For detection of cofilin–actin rods in brain, 70% ethanol was applied to 
sections for 5 min after washing the secondary antibody, followed by 0.1% Sudan Black B in 
70% ethanol for 12 min, two washes with 70% ethanol, several washes in Tris-buffered saline 
(TBS) before mounting. All immunoreactivities were quantitated from every 12th serial section 
through an entire hippocampus or anterior cortex. All images were acquired with the Olympus 
FV10i confocal microscope (Tokyo, Japan) and quantitated using the Image J software. 
Comparison images were acquired with identical laser intensity, exposure time, and filter. 
Adjustments to the brightness/contrast were applied equally to all comparison images. 
Fear conditioning, open field, and rotarod behavior 
Fear conditioning (contextual and cued), rotarod, and open field tasks were performed as 
previously described. For fear conditioning, an aversive stimulus (in this case a mild foot shock, 
0.5 mA) was paired with an auditory conditioned stimulus (white noise) within a novel 
environment. Training consisted of two mild shocks paired with two conditioned stimuli with a 
3-min interval between each shock. Freezing on the training day in response to the foot shock 
was used as an estimate of learning during the acquisition trial. To test conditioning to the 
context, animals were re-introduced to the same training chamber for 6 min and freezing 
behavior was recording by tracking software (Any-maze, Wood Dale, IL, USA) every second. 
To test conditioning to the tone, animals were introduced to a novel context, consisting of a 
chamber with different shape, floor and olfactory cues from the training chamber. Mice were 
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scored for 3 min, before and after the tone in the same manner described above. Learning was 
assessed by measuring freezing behavior (i.e., motionless position) every second. The open field 
was used as a standard test of general activity. Briefly, animals were monitored for 15 min in a 
40 cm square open field with a video tracking software (Any-maze). General activity levels were 
evaluated by measurements of total distance traveled. Motor performance was evaluated by an 
accelerating rotarod apparatus with a 3 cm diameter rod starting at an initial rotation of 4 r.p.m. 
slowly accelerating to 40 r.p.m. over 5 min. The time spent on the rod during each of four trials 
per day for 2 consecutive days was measured previously described in. 
Electrophysiology in mouse brain slices 
Hippocampus slices were prepared from 3-month-old WT, APP/PS1, and 
APP/PS1;RanBP9+/− mice and subjected to input/output curved, paired pulse facilitation, and 
LTP as previously described. Briefly, animals were killed, brains were harvested, and sectioned 
horizontally (400 μm) in ice-cold cutting solution (110 mM sucrose, 6 mM NaCl, 3 mM KCl, 26 
mM NaHCO3, 1.25 mM, NaH2PO4, 7 mM MgCl2, 0.5 mM CaCl2, 10 g/l glucose, pH 7.3–7.4). 
The hippocampus was dissected and acclimated in 50:50 solution (cutting:artificial cerebrospinal 
fluid (ACSF)) for 10 min at room temperature. Then the slices were transferred to ACSF (125 
mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 0.26 mM NaHCO3, 1.2 mM MgCl2, 2.0 mM 
CaCl2, and 10 g/l glucose, pH 7.3–7.4, saturated with 95% O2 and 5% CO2). Slices were 
recovered in ACSF at room temperature at least 40 min, followed by a final incubation in ACSF 
for 1 hour at 30 °C. Extracellular field potential recording, LTP: the recording chamber was held 
at 30± 0.5°C with ACSF flow rate of 1 ml/min. The stimulating electrode was placed in the 
Schaffer collaterals of the hippocampus. The recording glass electrode loaded with ACSF was 
positioned at the CA1 stratum radiatum below the pyramidal cell layer. Stimulating pulses were 
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generated by the Digidata 1322A interface (Molecular Devices, Sunnyvale, CA, USA) and a 
stimulus isolator (model 2200; A-M Systems, Sequim, WA, USA) under control of Clampex 
10.0 software (Molecular Devices). Field excitatory postsynaptic potentials (fEPSP) were 
amplified using a differential amplifier (model 1800; A-M Systems), filtered at 1 kHz, and 
digitized at 10 kHz. Input–output analysis was performed by stepping stimulation amplitude 
from 1 to 15mV. Stimulation amplitude that elicited half-maximal fEPSP was determined by the 
input–output curve and stimulation rate of 0.05 Hz was used through the whole experiment. PPF, 
which is short-term plasticity, was evoked by two pulses with interpulse intervals from 20 to 300 
ms. Percentage of the facilitation was calculated by dividing fEPSP slope elicited by the second 
pulse with the fEPSP slope elicited by the first pulse. LTP was induced by theta burst stimulation 
(TBS) (five trains of four pulses at 200 Hz separated by 200 ms, repeated six times with an inter-
train interval of 10 s). LTP was sampled 60 min after the induction, and calculated by dividing 
the slope of 60 min post-induction responses with the average slope of 20-min baseline 
responses. 
Results 
Endogenous RanBP9 mediates Aβ42 oligomer-induced translocation of cofilin to 
mitochondria and promotes cofilin activation via positively regulating SSH1 
We assessed whether Aβ oligomers alter Cofilin translocation to mitochondria and 
whether siRNA knockdown of RanBP9 might influence this phenotype. We prepared Aβ1-42 
oligomers precisely as previously characterized(Dahlgren et al., 2002), which contained SDS-
resistant dimers, trimers, and tetramers (Aβ42O) whereas freshly dissolved Aβ1-42 only 
contained monomers (Aβ 42M) (Fig. 3-1A). All stated Aβ42O concentrations heretofore are based 
on the monomer concentration. Hippocampus derived HT22 cells were transiently transfected 
with control or RanBP9 siRNA for 48 hours and subjected to treatment with or without Aβ42O 
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(1µM) for 2 hours, followed by separation of intact mitochondria and cytosol fractions. Aβ42O 
treatment increased both Cofilin and RanBP9 translocation to mitochondria (Fig. 1B). However, 
siRNA knockdown of endogenous RanBP9 mitigated AβO-induced Cofilin mitochondrial 
translocation (Fig. 3-1B,C). Aβ42 monomer exposure (1µM, 2h) neither promoted Cofilin 
translocation to mitochondria nor altered Cofilin activation (Supplemental Fig. S3-1A).  In vivo, 
RanBP9 levels were greatly decreased in the hippocampus of 3-month old APP/PS1;RanBP9+/- 
mice in both cytosol and mitochondrial fractions compared to APP/PS1 mice(Jankowsky et al., 
2004) (Fig. 3-1D). While Cofilin levels were unchanged in the cytosol fraction between the 
genotypes, Cofilin was significantly reduced in the hippocampal mitochondrial fraction of 
APP/PS1;RanBP9+/- mice compared to APP/PS1 mice (Fig. 3-1D,E), indicating that 
endogenous RanBP9 facilitates translocation of Cofilin to mitochondria in vivo. As expected, 3-
month old RanBP9+/- mice exhibited reduced RanBP9 protein together with significantly 
increased inactive phospho-Cofilin without altering total Cofilin (Fig. 3-1F,G), which was 
accompanied by significantly decreased SSH1 protein in RanBP9+/- mice (Fig. 1F-H), 
indicating that RanBP9 positively regulates SSH1 levels. Indeed, SSH1 but not LIMK1 levels 
were significantly increased secondary to RanBP9 overexpression in HT22 cells (Fig. 3-1I,J). 
Consistent with these observations, RanBP9 not only markedly increased SSH1 but also co-
immunoprecipitated with SSH1 in brain (Fig 3-1K). Accordingly, siRNA knockdown of RanBP9 
in HT22 cells strongly reduced the enhancement of Cofilin-SSH1 complex induced by Aβ42O 
treatment (Fig. 3-1L) while significantly decreasing SSH1 levels (Fig. 3-1L,M). In DIV21 
primary cortical neurons, Aβ42O (2h) marked increased RanBP9-SSH1 and Cofilin-SSH1 
complexes (Fig. 3-1N), suggesting that RanBP9 not only increases SSH1 levels but may also 
serve to facilitate Cofilin-SSH1 interaction upon Aβ42O exposure. To determine whether the 
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RanBP9-SSH1 complex alters SSH1 protein stability, we performed cycloheximide turnover 
experiments. Indeed, RanBP9 siRNA and overexpression marked accelerated and delayed the 
turnover of SSH1, respectively (Fig. 3-1O), confirming that RanBP9 positively regulates SSH1 
protein stability. 
Endogenous RanBP9 and SSH1 promote cofilin–actin rod formation and Aβ oligomer-
induced collapse of growth cones in primary hippocampal neurons.  
Hyperactive Cofilin can form Cofilin-saturated Actin filament bundles (or rods) when 
challenged by oxidative stress, excitotoxic insult, or Aβ oligomers in primary neurons. These 
Cofilin-Actin rods accumulate in neurites, which blocks neuritic transport of key cargo to distal 
locations(Cichon et al., 2012; Mi et al., 2013). To assess the role of RanBP9 in Cofilin-Actin rod 
formation, we transiently transfected GFP-Cofilin in wild type and RanBP9+/- hippocampal 
neurons. On DIV8, we treated neurons with a low concentration of hydrogen peroxide (1µM) for 
30 minutes, which is known to induce Cofilin-Actin rod formation. Wild type neurons formed 
significantly higher numbers of GFP-Cofilin rods per neuron and per neuronal cytoplasmic area 
(NCA) compared to RanBP9+/- neurons (Fig. 3-2A,B). We next treated DIV8 wild type and 
RanBP9+/- neurons with or without Aβ42O (1µM) for 24 hours, which has been shown to induce 
Cofilin-Actin rod formation in 10-20% of neurons(Maloney, Minamide, Kinley, Boyle, & 
Bamburg, 2005). We observed fewer percentage of neurons with Cofilin rod/aggregate-like 
structures in RanBP9+/- neurons (16.3% of WT neurons & 6.9% of RanBP9+/- neurons)(Fig. 3-
2C) as well as significantly reduced numbers of Cofilin rods/aggregates per neuron and per 
neuronal cytoplasmic area (NCA) compared to WT neurons upon Aβ42O treatment (Fig. 3-
2C,D). In addition, we observed the presence of F-Actin-positive growth cones in WT vehicle 
treated neurons, which largely collapsed in wild type neurons treated with Aβ42O (Fig. 3-2C,E).  
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However, F-Actin-positive growth cones were largely unaffected by Aβ42O in 
RanBP9+/- neurons (Fig. 3-2C,E), indicating that RanBP9 reduction protects against Cofilin-
Actin rod formation as well as Aβ42O-induced collapse of growth cones. Such changes in 
RanBP9+/- neurons were not due to gross alterations in the numbers or length of neurites (Fig. 
3-2F,G). However, Scholl analysis demonstrated that RanBP9+/- neurons exhibited subtle but 
significant increases in numbers of neurite intersections at certain distances from the soma at 
basal state on DIV9 (Fig. 3-2F,G). Similar to RanBP9 reduction, SSH1 siRNA also significantly 
prevented Cofilin rod/aggregate structures and collapse of growth cones induced by Aβ42O 
(1µM) exposure for 24 hours (Fig. 3-2H-J), indicating that RanBP9 reduction mitigates Aβ42O-
induced effects at least in part via negative regulation of SSH1. 
Endogenous RanBP9 mediates the depletion of postsynaptic proteins induced by Aβ 
oligomers in primary hippocampal neurons. 
Dendritic spines are structures critical for excitatory synaptic transmission and highly 
enriched in postsynaptic proteins such as Drebrin, PSD95, and F-Actin(Shirao & Gonzalez-
Billault, 2013). To assess synaptic perturbations induced by Aβ42O, we cultured P0 hippocampal 
neurons derived from RanBP9+/- and wild type littermate mice. We cultured neurons to DIV21 
to visualize mature dendritic spines and treated them with or without Aβ42O for 2 hours.  As 
expected, immunocytochemical analysis demonstrated that Aβ42O significantly depleted 
Drebrin, PSD95, and F-Actin in dendritic spines and spine-containing neurites in wild type 
neurons (Fig. 3-3A-D). However, the same Aβ42O treatment had no significant effects in 
RanBP9+/- neurons (Fig. 3-3A-D), indicating that endogenous level of RanBP9 is required for 
Aβ1-42O-induced depletion of postsynaptic proteins and F-Actin in mature neurons. Aβ42 
monomer treatment (1µM, 2h) did not appreciably alter Drebrin or F-Actin levels (Supplemental 
Fig. S3-1B). In DIV21 mature neurons, Scholl analysis demonstrated significantly increased 
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complexity and length of neurites beyond 50µm from the soma in RanBP9+/- vs. wild type 
neurons (Fig. 3-3E,F), supportive of a role for endogenous RanBP9 in the inhibition of neurite 
outgrowth and maturation. 
Significant increase in endogenous RanBP9 in APP/PS1 mice brains.     
We examined endogenous RanBP9 expression in the APP/PS1 mice expressing the 
‘Swedish’ and PS1ΔE9 mutation by immunoblotting and immunohistochemistry. Endogenous 
RanBP9 protein levels were significantly increased by 3.5-fold in the hippocampus of 8-month 
old APP/PS1 mice by immunoblotting (Fig. 3-4A,B), consistent with our previous observations 
in 12-month old J20 mice harboring the ‘Swedish’ mutation and in AD brains (M.K. Lakshmana 
et al., 2012; J. A. Woo et al., 2012). Further, immunohistochemical analysis of APP/PS1 mouse 
hippocampus demonstrated greatly enhanced RanBP9 levels in the dentate gyrus (DG) and CA3 
regions compared to wild type littermates (Fig. 3-4C). 
Rescue of neuroinflammation, synaptic damage, and Aβ ccumulation by RanBP9 reduction 
in APP/PS1 mice. 
Given the robust upregulation of RanBP9 levels in APP/PS1 mice, we next determined 
whether genetic reduction in RanBP9 can prevent neuroinflammation and synapse loss 
associated with APP/PS1 transgenic mice. We performed immunohistochemistry for GFAP and 
Iba1 to detect activated astrocytes and microglia as well as Synapsin I and PSD95 to detect pre- 
and post-synaptic proteins from 8-month old APP/PS1, APP/PS1;RanBP9+/-, and wild type 
(WT) littermates. As expected, APP/PS1 mice demonstrated significantly increased GFAP and 
Iba1 immunoreactivities throughout the hippocampus and areas of the anterior cortex associated 
with Aβ accumulation as well as diminished PSD95 and Synapsin I immunoreactivities within 
the stratum lucidium (SL: synaptic terminating zone) of CA3 (Fig. 3-5A,B). In contrast, 
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APP/PS1;RanBP9+/- mice showed significantly reduced GFAP and Iba1 immunoreactivities in 
the hippocampus and anterior cortex as well as significantly rescued Synapsin I and PSD95 
immunoreactivities within the SL of CA3 compared to APP/PS1 littermate mice, essentially 
indistinguishable from wild type mice (Fig 3-5A,B). Because RanBP9 overexpression promotes 
Aβ production in cultured cells and in vivo (M.K. Lakshmana et al., 2012; Lakshmana et al., 
2009), we next examined whether endogenous RanBP9 reduction alters Aβ burden in the 
hippocampus and anterior cortex of 8-month old APP/PS1 mice. Indeed, APP/PS1;RanBP9+/- 
mice demonstrated significantly decreased both total Aβ deposits and thioflavin S-positive 
fibrillar Aβ deposits within the hippocampus and anterior cortex compared to littermate 
APP/PS1 mice (Fig. 3-6A-C). In addition, soluble Aβ levels were also significantly reduced in 
the hippocampus of APP/PS1;RanBP9+/- mice compared to littermate APP/PS1 mice (Fig. 3-
6D,E). These results demonstrate that RanBP9 reduction protects against Aβ accumulation as 
well as neuroinflammation and synaptotoxicity in vivo. 
Accumulation of Cofilin-Actin Rods in APP/PS1 mice and Significant Attenuation of 
Cofilin-Actin Rod Formation by RanBP9 Reduction. 
Given the positive regulation of SSH1 and Cofilin as well as Cofilin-Actin rods in 
primary neurons by RanBP9, we assessed Cofilin-Actin rods / aggregates in wild type, APP/PS1, 
and APP/PS1;RanBP9+/- brains. For this, we used Sudan Black B to quench background and the 
more diffuse non-rod staining. Therefore, only intense signals, such as rods, are visualized while 
removing normal cytoplasmic immunoreactivity. Using this method, we found that Cofilin rods / 
aggregates were readily detectable in the hippocampus and anterior cortex of 9-month old 
APP/PS1 mice, while very few were found in wild type (WT) mice (Fig. 3-7A). Such Cofilin 
rod/aggregate structures, which colocalized with Actin, were significantly increased by ~10-fold 
in APP/PS1 vs. WT mice (Fig. 3-7A-C) and resembled those seen in AD brains (Fig. 3-7D). 
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RanBP9 reduction significantly attenuated Cofilin-Actin rod / aggregate formation, although not 
completely to the level of WT mice (Fig. 3-7A-C). In the AD entorhinal cortex, Cofilin rod / 
aggregate structures were numerous and overwhelmingly did not colocalize with 12E8-positive 
phospho-Tau immunoreactivity, albeit within the same region and in close proximity (Fig. 3-
7D). These findings in vivo confirm our findings in primary neurons that RanBP9 reduction 
ameliorates Cofiin-Actin pathology in an in vivo mouse model of Aβ accumulation. 
RanBP9 reduction rescues deficits in synaptic plasticity and contextual memory associated 
with APP/PS1 mice.   
We tested short-term and long-term synaptic plasticity from acute hippocampal slices 
prepared from 3-month-old WT, APP/PS1, RanBP9+/−, and APP/PS1;RanBP9+/− mice, an age 
when little to no Aβ plaques are detected. The stimulating electrode was placed in the Schaffer 
collaterals of the hippocampus, and the recording electrode was positioned at the CA1 stratum 
radiatum below the pyramidal cell layer. As shown in Figure 3-8A, input–output analysis did not 
markedly differ among WT, APP/PS1, and APP/PS1;RanBP9+/−, and RanBP9+/−slices. 
However, the APP/PS1;RanBP9+/− slices showed a nonsignificant decrease in basal synaptic 
transmission compared with WT, RanBP9+/−, and APP/PS1 slices (Figure 3-8a). In paired pulse 
facilitation (PPF) experiments, significant differences were observed in fEPSP slope across 
genotypes among all interstimulus intervals (Figure 3-8b). Correction for multiple comparisons 
surprisingly showed that APP/PS1;RanBP9+/− slices exhibited significantly higher PPF 
compared with both WT, RanBP9+/−, and APP/PS1 slices across most interstimulus intervals 
(Figure 3-8b), indicating a synergistic effect of RanBP9 and APP/PS1 genotypes on cooperative 
presynaptic efficacy. For long-term potentiation (LTP) measurements, we detected no 
differences in fEPSP slope among WT, APP/PS1, RanBP9+/−, and APP/PS1;RanBP9+/− slices 
at baseline (Figure 3-8c). However, after theta burst stimulation, we observed significant 
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differences in fEPSP slope across genotypes for all time points (Figure 3-8c). Correction for 
multiple comparisons showed that APP/PS1 slices were significantly impaired in fEPSP slope 
compared with WT, RanBP9+/−, and APP/PS1;RanBP9+/− slices at every time point up to 
1 hour (Figure 3-8c). APP/PS1;RanBP9+/− slices exhibited significantly stronger fEPSP slope 
across all time points compared with WT and APP/PS1 slices (Figure 3-8c), indicating that 
RanBP9 reduction greatly enhances both the induction and maintenance of LTP. Similarly, 
RanBP9+/− slices exhibited significantly stronger LTP than WT slices up to 30 min and did not 
significantly differ from APP/PS1;RanBP9+/− slices (Figure 3-8c). Therefore, these results 
indicate that RanBP9 reduction not only rescues the deficits in synaptic plasticity associated with 
the APP/PS1 mice but also further potentiates synaptic plasticity. 
Discussion 
Molecular pathways that govern the neurotoxicity and production of Aβ are attractive 
therapeutic targets for AD. In this study, we utilized HT22 cells, primary neurons, acute brain 
slices, and genetically modified mice to gain insights into the role of endogenous RanBP9 in Aβ-
induced synaptic degeneration, Cofilin activation, Cofilin-Actin rod formation, and Aβ 
accumulation in a mouse model of AD. We made a number of novel observations demonstrating 
that endogenous RanBP9 positively regulates SSH1 levels and is critical for Aβ-induced 
translocation of Cofilin to mitochondria, Cofilin-Actin rod/aggregate formation, collapse of 
growth cones, loss of synaptic proteins, and impairments in synaptic plasticity and 
learning/memory. Our findings underscore the critical importance of the RanBP9-SSH1-Cofilin 
pathway in AD pathogenesis. 
A prerequisite for Cofilin translocation to mitochondria and formation of Cofilin-Actin 
rods is its activation via dephosphorylation and oxidation on several cysteine residues (B. W. 
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Bernstein et al., 2012; Klamt et al., 2009). Therefore, the observation that Aβ oligomers induced 
Cofilin translocation to mitochondria and formation of Cofilin-Actin rods infers its rapid 
activation and oxidation by Aβ oligomers. Interestingly, AβO also increased RanBP9 
translocation to mitochondria, which may in part be explained by its association with the pro-
apoptotic mitochondria-associated protein P73 (Liu et al., 2013). Genetic reduction and siRNA 
knockdown of RanBP9 significantly mitigated both of these measures and reduced Cofilin 
activation. As Cofilin is activated by SSH1-dependent dephosphorylation and inactivated by 
LIMK-dependent phosphorylation, it is plausible that RanBP9 alters one or both of these 
pathways. Indeed, we found that RanBP9 positively regulates SSH1 but not LIMK1 levels in 
HT22 cells and in brain, which accounts for increased Cofilin activation by RanBP9. As RanBP9 
levels are robustly increased in APP/PS1 mouse brains, it is likely that AβO also activates Cofilin 
via a mechanism involving RanBP9 and SSH1. Aβ is known to increase cytosolic Ca2+ and 
activate Calcineurin as well as enhance production of reactive oxygen species (ROS)(Butterfield, 
Swomley, & Sultana, 2013; Reese & Taglialatela, 2011), both of which are known activators of 
SSH1. Calcineurin-dependent dephosphorylation of SSH1 serves to activate SSH1 (Y. Wang, 
Shibasaki, & Mizuno, 2005b), and cysteine oxidation of 14-3-3 removes the inhibition of SSH1 
by 14-3-3(J. S. Kim et al., 2009). In addition, cysteine oxidation of Cofilin itself is required for 
both mitochondrial translocation and Cofilin-Actin rod formation (B. W. Bernstein et al., 2012; 
Klamt et al., 2009). We recently showed that AβO promotes Cofilin-Actin rod formation via a 
pathway requiring PrPc and NADPH oxidase (NOX), the latter which is involved in the 
generation of ROS (K. P. Walsh et al., 2014). We have also shown that AβO and RanBP9 impair 
mitochondrial Ca2+ buffering and promote mitochondrial superoxide production in a Cofilin-
dependent manner (Roh et al., 2013a; J. A. Woo et al., 2012). Therefore, the engagement of AβO 
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to its neuronal receptors likely involves downstream Ca2+ and ROS from multiple sources. 
Activated/oxidized Cofilin likely contributes to sustaining this cycle by promoting mitochondrial 
superoxide production.  
We observed that RanBP9+/- neurons are resistant to Aβ oligomer-induced collapse of F-
Actin containing growth cones in immature DIV9 neurons and depletion of postsynaptic proteins 
(Drebrin, PSD95, and F-Actin) in mature DIV21 neurons. Such findings are likely explained, at 
least in part, by the reduction in Cofilin activation status in RanBP9+/- neurons. Specifically, 
phosphorylation and dephosphorylation of Cofilin are associated with dendritic spine growth and 
shrinkage during LTP and LTD, respectively (Chen et al., 2007; Rex et al., 2009; Zhou et al., 
2004), and Cofilin regulates the trafficking of AMPA receptors in dendritic spines (Gu et al., 
2010). Further, β-Arrestin 2 recruits Cofilin to dendritic spines upon NMDA receptor activation 
to control the remodeling of spines, and β-Arrestin 2 knockout neurons are resistant to Aβ-
induced dendritic spine loss through spatial control of Cofilin activation (Pontrello et al., 2012).  
Despite the crucial involvement of Cofilin in synaptic plasticity, the aforementioned mechanism 
alone is unlikely to explain the full extent of the rescue and enhancement of LTP and PPF 
associated with APP/PS1;RanBP9+/- mice, since both LTP and PPF in were strongly enhanced 
significantly beyond those of wild type slices. However, in the absence of the APP/PS1 
genotype, RanBP9+/- mice exhibited normal PPF but significantly enhanced LTP.  The 
exaggerated PPF in APP/PS1;RanBP9+/- slices may be explained by lower probability of Ca2+-
evoked neurotransmitter release as evidenced by somewhat reduced fEPSP slope per stimulus 
amplitude (input/output curve). However, the second paired Ca2+ signal appears to 
overcompensate to release a larger pool of neurotransmitter. We hypothesize that RanBP9 
reduction enhances synaptic associativity and cooperativity perhaps at the level of synapse 
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formation and maintenance. Indeed, RanBP9+/- slices produced significantly enhanced LTP 
compared to WT and did not differ significantly from APP/PS1;RanBP9+/- slices. 
Overexpression of RanBP9 significantly reduces axon elongation in the chick spinal cord via 
Plexin-A (H. Togashi, E. F. Schmidt, & S. M. Strittmatter, 2006), and we also showed in this 
study that reduction in RanBP9 increases neurite arborization/complexity in mature neurons and 
protects against both Aβ oligomer-induced growth cone collapse and dendritic postsynaptic 
protein depletion. Previous studies have also shown the involvement of RanBP9 in negatively 
regulating β1-integrin function (J.A. Woo et al., 2012) and a role in the nucleocytoplasmic 
regulation of cell morphology via its interaction with muskelin (Valiyaveettil et al., 2008a).   
Therefore, RanBP9 may be involved in regulating neuritogenesis, synaptic maintenance, and 
synaptic plasticity changes via these pathways in addition to Cofilin activation.  
RanBP9 reduction protected against both AβO- and hydrogen peroxide-induced Cofilin-
Actin rod formation in primary neurons, thereby indicating a direct effect of RanBP9 and SSH1 
reduction on Cofilin-Actin rods. Indeed, SSH1 reduction per se significantly mitigated Aβ42O-
induced Cofilin rod/aggregate formation and collapse of growth cones, indicating that SSH1 
reduction, at least in part, is responsible for such effects of RanBP9. In vivo, however, RanBP9 
reduction mitigated both Cofilin-Actin rod/aggregate formation and Aβ accumulation/plaques. 
Therefore, it is likely that RanBP9 reduction lowers Cofilin-Actin rod/aggregate formation both 
directly via SSH1 regulation and indirectly by reducing Aβ accumulation. Cofilin-Actin rods are 
thought to be an initial protective response to oxidative insults (B.W. Bernstein, Chen, Boyle, & 
Bamburg, 2006); however, persistent accumulation of rods physically blocks neuritic transport of 
cargo and impairs synaptic activity (Cichon et al., 2012; Mi et al., 2013). Inhibition of RanBP9 
and SSH1 may not be sufficient to fully block Cofilin-Actin pathology, as ROS pathways acting 
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directly on Cofilin may also promote Cofilin-Actin pathology. In this light, it is intriguing that 
Tau overexpression induces Cofilin-Actin pathology and potently increases F-Actin bundling 
(Fulga et al., 2007) while disrupting mitochondrial fission via an Actin-dependent mechanism 
(DuBoff, Gotz, & Feany, 2012).  
Conclusion 
Taken together, this study demonstrated the crucial involvement of endogenous RanBP9 in Aβ-
induced Cofilin activation via SSH1 and downstream consequences on Cofilin-Actin rod 
formation, Aβ accumulation, synaptic plasticity, and contextual memory. These findings 
underscore the role of RanBP9 and its associated molecular pathway as critical mediators of AD 
pathology and potential therapeutic targets. 
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Figure 3-1. RanBP9 mediates Aβ oligomer-induced translocation of cofilin to mitochondria and lowers cofilin 
activation via SSH1. 
a) Aβ1-42 monomers (Aβ42M) or Aβ1-42 oligomer preparation (Aβ42O) subjected to SDS-PAGE and immunoblotted for Aβ. 
Note the monomer (M), dimers (Di), trimmers (Tri), and tetramemers (Tet) in the oligomer preparation. b & c) Hippocampus-
derived HT22 cells transiently transfected with control or RanBP9 siRNA for 48 h, treated with/without Aβ oligomers for 
2 hours, separated for mitochondrial and cytosol fractions, and subjected to immunoblotting for the indicated proteins. A 
representative experiment is shown. Notice the reduction phospho-cofilin upon Aβ oligomers treatment but mitigated response in 
RanBP9 siRNA knocked down cells. c) Quantitation of mitochondrial cofilin (ANOVA, post-hoc Tukey, **P<0.005, n=3 
replicates). d & e) Hippocampal extracts from 3-month-old APP/PS1 and APP/PS1;RanBP9+/− mice subjected to separation of 
mitochondrial and cytosol fractions and immunoblotted for the indicated proteins. Note the reduced level of cofilin in 
mitochondrial fraction of APP/PS1;RanBP9+/− brain. e) Quantitation of mitochondrial cofilin (t-test, **P<0.005, n=4 mice per 
genotype).  f-h) Hippocampal extracts from 3-month-old WT and littermate RanBP9+/− (Ran9+/−) mice subjected to 
immunoblotting for the indicated proteins. g) Quantitation of P-cofilin in hippocampus (t=2.74, P=0.022, *P<0.05, n=5 mice per 
genotype). h) Quantitation of SSH1 (t-test, **P=0.0016, n=4 mice per genotype). i & j) HT22 cells transiently transfected with 
vector control (Vec) or Flag-RanBP9 and immunoblotted for the indicated proteins. Note the increase in SSH1 but not LIMK1 by 
RanBP9 overexpression. j) Quantitation of SSH1 (t-test, ***P<0.0001, n=4 replicates). Error bars represent S.E.M. on graphs. k) 
Cortex (CTX) and hippocampus (HIPP) homogenates of 6-month-old WT or littermate Flag-RanBP9 transgenic (TG) mice 
immunoprecipitated for SSH1 and/or immunoblotted for the indicated proteins. Note the increase in SSH1-RanBP9 complex in 
Flag-RanBP9 transgenic mice (TG). l) HT22 cells transiently transfected with/without RanBP9 siRNA and treated with/without 
Aβ oligomers (1 μM) for 2 hours followed by immunoprecipitation for SSH1 and/or immunoblotting for the indicated proteins. 
Note that RanBP9 siRNA reduces SSH1 levels and decreases Aβ oligomers-induced enhancement of cofilin–SSH1 interaction. 
m) Quantitation of SSH1 protein levels with/without RanBP9 siRNA transfection in HT22 cells (t-test, ***P=0.0008, n=4 
replicates). n) DIV18 cortical primary neurons treated with or without Aβ42O (1 μM) for 2 hours, subjected to 
immunoprecipitation for SSH1, and/or immunoblotting for the indicated proteins. Note the increase in RanBP9-SSH1 and 
cofilin-SSH1 complex formation with Aβ42 oligomers treatment. o) HT22 cells transiently transfected with control, RanBP9 
siRNA, or RanBP9 and subjected to cycloheximide (CHX) treatment for the indicated times followed by immunoblotting for 
SSH1 or actin. Representative blots adjusted to show similar signal at time 0. Note that RanBP9 siRNA and overexpression 
accelerates and delays SSH1 turnover, respectively 
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Figure 3-2. RanBP9 mediates cofilin–actin rod formation and Aβ oligomer-induced collapse of growth cones 
in primary hippocampal neurons.  
a & b) DIV8 hippocampal neurons from WTand RanBP9+/− mice transiently transfected with cofilin-GFP and treated with 
hydrogen peroxide (1 μM) for 30 min and subjected to F-actin staining (Rhodaminephalloidin). Representative images showing 
marked reduction in cofilin-GFP rods in RanBP9+/− neurons, despite strong GFP cofilin fluorescence. b) Quantitation of cofilin-
GFP rods per neuron (t-test, **P= 0.0029, n= 6 replicates from three pups per genotype) or per NCA (t-test, **P =0.0009, n=6 
replicates from three pups per genotype) after treatment of hydrogen peroxide (1 μM) for 30 min. c-e) DIV8 hippocampal 
neurons from WTand RanBP9+/− mice treated with or without Aβ oligomers for 24 hours and subjected to staining for F-actin 
(Rhodamine-phalloidin) and cofilin. c) Representative images showing no cofilin rods observed without Aβ oligomers treatment 
but 16.3% and 6.9% of WTand RanBP9+/− neurons, respectively, contain cofilin rods. Also note the near absence of F-actin 
containing growth cones in WT neurons treated with Aβ42O but not in RanBP9+/− neurons. d) Quantitation of Cofilin rods per 
neuron (t-test, *P=0.0329, n=6 replicates) or per NCA (t-test, *P =0.030, n=6 replicates from three pups per genotype). e) 
Quantitation of F-actin containing growth cones in WT and RanBP9+/− (Ran9+/−) neurons with or without Aβ oligomers 
treatment (ANOVA, post-hoc Tukey, ***P<0.0001, n=8 replicates from four pups per genotype). f & g) Sholl analysis of neurite 
arborization/elongation in WT and RanBP9+/− hippocampal neurons on DIV9. f) Representative images of saturated F-actin 
stain. g) Quantitation of neurite intersections on concentric circles from the soma in 10μm increments (10–200 μm) (two-way 
ANOVA, post-hoc Bonferroni, *P<0.05, ^P<0.005, #P<0.0005, n=3 replicates from two mice per genotype). Error bars 
represent S.E.M. in graphs. H-J) DIV8 hippocampal neurons from WT mice with or without control or SSH1 siRNA transfection 
treated with or without Aβ oligomers for 24 hours and subjected to staining for F-actin and cofilin. h) Representative images 
showing cofilin and F-actin stains. i) Quantitation of cofilin rods per NCA (t-test, ***P<0.0001, n=6 replicates from three pups 
per genotype). j) Quantitation of F-actin containing growth cones in neurons transfected with control or SSH1 siRNA with or 
without Aβ42O treatment (ANOVA, post-hoc Tukey, ***P<0.0001, n=8 replicates from four pups per genotype)  
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Figure 3-3. RanBP9 mediates the depletion of postsynaptic proteins and F-actin induced by Aβ oligomers in 
mature primary hippocampal neurons. 
a-d) DIV21 primary hippocampal neurons derived from P0 RanBP9+/− and WT littermate mice treated with or without Aβ 
oligomers (1 μM) for 2 hours and subjected to immunocytochemistry for Drebrin, PSD95, and F-actin (Rhodamine-phalloidin). 
a) Representative images showing Aβ42 oligomer-induced depletion of Drebrin, PSD95, and F-actin in WT neurons but not in 
RanBP9+/− neurons. b) Quantitation of Drebrin intensity in secondary and tertiary spine-containing dendrites (ANOVA, post-
hoc Tukey, ***P<0.0005, n=9 replicates from three pups per genotype). c) Quantitation of PSD95 intensity in secondary and 
tertiary spine-containing dendrites (ANOVA, post-hoc Tukey, ***P<0.0005, n=10 replicates from three pups per genotype). d) 
Quantitation of F-actin (Rhodamine-phalloidin) intensity in secondary and tertiary spine-containing dendrites (ANOVA, post-hoc 
Tukey, **P<0.005, *P<0.05, n=4 replicates from two pups per genotype). Error bars represent S.E.M. on graphs. e & f) Sholl 
analysis of neurite arborization/elongation in WT and RanBP9+/− hippocampal neurons on DIV21. e) Representative images of 
saturated F-actin stain. f) Quantitation of neurite intersections on concentric circles from the soma in 10μm increments (10–220 
μm) (two-way ANOVA, post-hoc Bonferroni, *P<0.05, #P<0.0005, n=3 replicates from two pups per genotype). Error bars 
represent S.E.M. in graphs. 
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Figure 3-4. Increased endogenous RanBP9 levels in APP/PS1 mice 
a & b) Hippocampal extracts from 8-month-old WT and littermate APP/PS1 mice immunoblotted for the indicated proteins. a) 
Representative blots showing a robust increase in endogenous RanBP9 protein together with overexpression of human APP 
(6E10 antibody). b) Quantitation of endogenous RanBP9 protein levels in WT and APP/PS1 hippocampus normalized to WT (t-
test, **P=0.0016, n=4 mice per genotype, 2 F and 2 M). c) Representative immunohistochemical images of endogenous RanBP9 
immunostaining within the dentate gyrus (DG) and CA3 of the hippocampus. 
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Figure 3-5. RanBP9 reduction rescues neuroinflammation and synaptic protein depletion in APP/PS1 
transgenic mice. 
a-e) Brains from 8-month-old WT, APP/PS1, and APP/PS1;RanBP9+/− mice subjected to immunohistochemistry for GFAP 
(activated astrocyte marker), Iba1 (activated microglia marker), Synapsin I (presynaptic marker), and PSD95 (postsynaptic 
marker) in the anterior cortex (CTX) and/or hippocampus (HIPP). A) Representative images showing RanBP9 reduction rescues 
neuroinflammation (GFAP and Iba1) and synaptic protein loss (Synapsin I and PSD95) in APP/PS1 mice. b) Quantitation of 
PSD95 intensity within the SL of CA3 (ANOVA, post-hoc Tukey, *P<0.05, **P<0.005, n=4 mice per genotype, 2 F and 2 M). 
Quantitation of synapsin I intensity within the SL of CA3 (ANOVA, post-hoc Tukey, *P<0.05, **P<0.005, n=4 mice per 
genotype, 2 F and 2 M). Quantitation of GFAP intensity in the hippocampus (ANOVA, post-hoc Tukey, *P<0.05, n=4 mice per 
genotype, 2 F and 2 M). Quantitation of GFAP intensity in the anterior cortex (ANOVA, post-hoc Tukey, **P=<0.005, 
***P<0.0005, n=4 mice per genotype, 2 F and 2 M). Quantification of Iba1 intensity in the hippocampus (ANOVA, post-hoc 
Tukey, ***P<0.0005, n=4 mice per genotype, 2 F and 2 M). Error bars represent S.E.M. on graphs. 
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Figure 3-6. Mitigation of Aβ accumulation by RanBP9 reduction in APP/PS1 mice. 
a) Representative immunohistochemical images showing reductions in Aβ deposits (red) in the anterior cortex and hippocampus 
of 8-month-old APP/PS1;RanBP9+/− mice compared with littermate APP/PS1 mice. b) Representative images showing 
reductions in thioflavin S-positive fibrillar Aβ deposits in the anterior cortex and hippocampus of 8-month-old 
APP/PS1;RanBP9+/− mice compared with littermate APP/PS1 mice. c) Quantitation of area covered by Aβ deposits normalized 
to APP/PS1 mice in the anterior cortex and hippocampus (Cortex: t-test,*P=0.0155, n=4 each; Hippocampus: t-test, **P=0.0067, 
n=4 mice per genotype, 2 F and 2 M). Quantitation of area covered by thioflavin S-positive fibrillary Ab deposits in the anterior 
cortex and hippocampus (t-test, ***P<0.0005, n=4 mice per genotype, 2 F and 2 M). Error bars represent S.E.M. in graphs. d) 
Hippocampal extracts from 6-month-old WT, APP/PS1, and APP/PS1;RanBP9+/− mice immunoblotted for human APP (6E10—
Triton-X100 extract) and Aβ (PBS extract). e) Quantification of soluble Aβ levels (PBS extract) from 6-month-old APP/PS1 and 
APP/PS1;RanBP9+/− hippocampus (t-test, *P=0.0167, n=3 mice per genotype) 
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Figure 3-7 Accumulation of cofilin–actin rod/aggregate structures in APP/PS1 mice.  
a-c) Nine-month-old WT, APP/PS1, and APP/PS1;RanBP9+/− littermate brains subjected to immunohistochemistry for cofilin 
and actin in the anterior cortex and hippocampus using Sudan black to quench background signal. a) Representative images 
showing increased cofilin–actin rods in APP/PS1 mice and reduction in APP/PS1;RanBP9+/− mice. b & c) Quantitation of 
cofilin–actin rods in the hippocampus and anterior cortex normalized to WT (ANOVA, post-hoc Tukey, **P<0.005, 
***P<0.0005, n=4 mice per genotype). Error bars represent S.E.M. in graphs. d) Representative images of cofilin–actin rods and 
neuropil threads (phospho-Tau 12E8 antibody) using the same Sudan black quenching immunohistochemical method  in the 
entorhinal cortex from a cognitively normal control (NC) and AD. Note the marked accumulation of cofilin–actin rods (green) 
and neuropil threads (red) in AD but few in NC. 
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Figure 3-8 Rescues of synaptic plasticity and contextual memory impairments in APP/PS1 mice by RanBP9 
reduction.  
a-c) Stimulating electrode placed in the Schaffer collaterals of the hippocampus and recording glass electrode positioned at the 
CA1 stratum radiatum below the pyramidal cell layer. a) Input–output analysis performed by stepping up stimulation amplitude 
from 1–15mV in WT, APP/PS1, RanBP9+/−, and APP/PS1;RanBP9+/− acute slices. No significant differences observed. Slices 
from WT n=45, RanBP9+/− n=31, APP/PS1 n=19, APP/PS1;RanBP9+/− n=25; slices derived from four to six mice per 
genotype.  b) PPF showing significant differences among all interstimulus intervals (two-way ANOVA, genotype: P<0.0001; 
interstimulus interval: P<0.0001; interaction: P=0.0122). Post-hoc Tukey test shows significant increases in fEPSP slope in 
APP/PS1;RanBP9+/− slices compared with WT, RanBP9+/−, and APP/PS1 slices at nearly all interstimulus intervals (P<0.05 to 
P<0.0001). Slices from WT n=49, RanBP9+/− n=33. APP/PS1 n=31, APP/PS1;RanBP9+/− n=25; slices derived from four to 
six mice per genotype. c) No significant changes between genotypes at baseline before LTP but LTP induced by theta burst 
stimulation showing significant differences in fEPSP slope among WT, APP/PS1, RanBP9+/−, and APP/PS1;RanBP9+/− slices 
(two-way ANOVA, genotype: P<0.0001; time: P<0.0001; interaction: P<0.0001). Post-hoc Tukey test shows significant 
differences between all genotypes at all-time points after theta burst stimulation (P<0.0001) except between RanBP9+/− versus 
APP/PS1;RanBP9+/−. Slices from WT n=41, RanBP9+/− n=28, APP/PS1 n=33, APP/PS1;RanBP9+/− n=29; slices derived from 
four to six mice per genotype. d) Quantitation of contextual fear conditioning (FC) freezing times (sec) after training session 
24 hours earlier across genotypes. Kruskal–Wallis ANOVA, post-hoc Dunn’s, *P<0.05, WT n=12 (5 F and 7 M), APP/PS1 n=8 
(4 F and 4 M), APP/PS1;RanBP9+/− n=6 (3 F and 3 M). e) Quantitation of cued fear conditioning (FC) freezing times (sec) 
across genotypes (no significant differences by Kruskal–Wallis test or one-way ANOVA). Same number and gender as 
contextual FC. f) Quantitation of open field activity test (total distance traveled over two- day training sessions) across genotypes 
(no significant differences by Kruskal–Wallis test or one-way ANOVA). Same numbers and gender as contextual FC. g) 
Quantitation of rotarod test (time staying on rotarod) across genotypes (no significant differences by Kruskal–Wallis test or one-
way ANOVA). Error bars represent S.E.M. in graphs. Same number and gender as contextual FC 
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Supplementary Figure 3-1 Short-term Aβ Monomer Exposure Does Not Alter Cofilin Translocation to 
Mitochondria or Drebrin/F-Actin Levels 
(A) Hippocampus-derived HT22 cells treated with/without A42 monomers for 2h, separated for mitochondrial and cytosol 
fractions, and subjected to immunoblotting for the indicated proteins. A representative experiment shows no effect of A42 
monomers in Cofilin translocation to mitochondria or activation status. (B) DIV21 primary hippocampal neurons derived from 
P0 RanBP9+/- and wild type (WT) littermate mice treated with or without A42 monomers (1M) for 2h and subjected to 
immunocytochemistry for Drebrin and F-Actin (Rhodamine-phalloidin). Representative images show no effect of A42 
monomers on Drebrin or F-Actin levels.  
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CHAPTER 4 
 
DISCUSSION 
Summary 
The major defining pathological hallmarks of Alzheimer’s disease (AD) are the 
accumulations of amyloid β (A) and hyperphosphorylated Tau, associated with 
neuroinflammation, mitochondrial dysfunction, cytoskeletal aberrations, and synaptic loss. 
Multiple studies have shown that A-induced neurotoxic signals require Tau, since the loss of 
Tau abrogates many deleterious effects of A (Morris et al., 2011; Vossel et al., 2015; Vossel et 
al., 2010). Despite the clear pathogenic link between A and Tau, a large knowledge gap exists 
in how A pathogenically impinges on Tau. In the preceding studies, we have addressed some of 
the early and as yet unknown gaps in the neurotoxic signaling pathways resulting from the 
accumulation of A oligomers at the level of the cell surface and subsequent downstream 
signaling pathways. Our findings demonstrate the critical involvement of 1-integrin receptor 
complexes on the neuronal surface and subsequent activation SSH1, resulting in hyperactivation 
of Cofilin. Such activation leads to neurodegenerative changes in integrin-dependent focal 
complexes, destabilization of F-Actin, and mitochondrial dysfunction. Specifically, we found 
that Aβ42 oligomers bind with high affinity to low or intermediate activation conformers of β1-
integrin, resulting in the loss of surface β1-integrin and activation of Cofilin via Slingshot 
homology-1 (SSH1) activation. Conditional loss of β1-integrin prevented Aβ42 oligomer-
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induced Cofilin activation, and allosteric modulation or activation of β1-integrin significantly 
reduced Aβ42 binding to neurons while blocking Aβ42 oligomer-induced reactive oxygen 
species (ROS) production, mitochondrial dysfunction, depletion of F-actin/focal Vinculin, and 
apoptosis. Cofilin, in turn, was required for Aβ42 oligomer-induced loss of cell surface β1-
integrin, disruption of F-actin/focal Talin–Vinculin, and depletion of F-actin-associated 
postsynaptic proteins. SSH1 reduction, which mitigated Cofilin activation, prevented Aβ42 
oligomer-induced mitochondrial Cofilin translocation and apoptosis, while AD brain 
mitochondria contained significantly increased activated/oxidized Cofilin. In mechanistic 
support in vivo, AD mouse model (APP/PS1) brains contained increased SSH1/Cofilin and 
decreased SSH1/14-3-3 complexes, indicative of SSH1–Cofilin activation via release of SSH1 
from 14-3-3. Finally, genetic reduction in Cofilin rescued APP/Aβ-induced synaptic protein loss 
and gliosis in vivo as well as deficits in long-term potentiation (LTP) and contextual memory in 
APP/PS1 mice.  
Our findings indicated that activation of SSH1 and Cofilin is not only achieved A-
induced oxidation of 14-3-3 but also is mediated by RanBP9. Specifically, we found that 
endogenous RanBP9 positively regulates SSH1 levels and mediates Aβ-induced translocation of 
cofilin to mitochondria and induction of cofilin–actin pathology in cultured cells, primary 
neurons, and in vivo. Endogenous level of RanBP9 was also required for Aβ-induced collapse of 
growth cones in immature neurons (days in vitro 9 (DIV9)) and depletion of synaptic proteins in 
mature neurons (DIV21). In vivo, APP/PS1 mice exhibited 3.5-fold increased RanBP9 levels, 
which is consistent with that observed in brains of AD patients. Accordingly, RanBP9 reduction 
in APP/PS1 mice protected against cofilin–actin pathology, synaptic damage, gliosis, and Aβ 
accumulation associated with APP/PS1 mice. Brains slices derived from APP/PS1 mice showed 
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significantly impaired long-term potentiation (LTP), and RanBP9 reduction significantly 
enhanced paired pulse facilitation and LTP, as well as partially rescued contextual memory 
deficits associated with APP/PS1 mice.   
Conclusion 
These novel findings therefore implicate the essential involvement of the β1-integrin–
SSH1–Cofilin pathway in mitochondrial and synaptic dysfunction in AD and underscore the 
critical convergence of endogenous RanBP9 not only in Aβ production but also in mediating the 
neurotoxic actions of Aβ at the level of synaptic plasticity, mitochondria, and cofilin–actin 
pathology via control of the SSH1-cofilin pathway in vivo. As such, targeting SSH1, a relatively 
druggable target with a rigid catalytic pocket, may be an attractive and novel therapeutic strategy 
for AD. 
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